BACTERIOPHAGE NANOFIBERS ENABLED NANOSTRUCTURES AND TARGET-RECOGNITION FOR BIO-APPLICATIONS by Xu, Hong










BACTERIOPHAGE NANOFIBERS ENABLED NANOSTRUCTURES AND 










SUBMITTED TO THE GRADUATE FACULTY 
 





























A DISSERTATION APPROVED FOR THE 












































































© Copyright by HONG XU 2015 
All Rights Reserved. 
  
Dedication 
This dissertation is dedicated to my brilliant, loving, and supportive husband, 
Binrui, and our brave, sweet, and kind-hearted little boy, Brady, and to my always 




Over the past seven years, I have received support from a great number of 
individuals. I would never have been able to finish my dissertation without the guidance 
of my committee members, help from colleagues and friends, and support from my 
family.  
Dr. Chuanbin Mao has been a mentor, colleague, and friend. His guidance has 
made my Ph.D. pursuit to be a thoughtful and rewarding journey. I would like to thank 
him for his excellent guidance, caring, patience and providing me great supports for 
doing research. I would like to express my gratitude to my committee members, Dr. 
Wai Tak Yip, Dr. Shaorong Liu, Dr. Zhibo Yang, and Dr. Lloyd Bumm for their 
support over the past years. In addition, I would like to than Dr. Ashby and Dr. Cook 
who attended my qualification defense.  
During data collection and writing, Dr. Chuanbin Mao and Dr. Binrui Cao spent 
hours proofreading and listening to my talk of research. Dr. Haibo Zhu and Dr. Kun Ma 
generously provided me collaboration to my research, as I could not finish the work 
without their help. I would also like to thank all the members in Dr. Mao’s lab for their 
support and collaboration over the years. 
Finally, I would like to thank my parents and my husband. They are always 
there supporting me and encouraging me through the good times and bad.  
 
v 
Table of Contents 
Acknowledgements ......................................................................................................... iv	
List of Tables ................................................................................................................... xi	
List of Figures ................................................................................................................. xii	
Abstract ......................................................................................................................... xvii	
Chapter 1:	 Introduction .................................................................................................. 1	
1.1	 Filamentous Bacteriophage Biology ................................................................. 2	
1.1.1	 Phage structure as a biological nanorod ................................................... 2	
1.1.2	 Phage Life Cycle ...................................................................................... 6	
1.2	 Phage display: displaying a peptide on the surface to change the surface 
chemistry ........................................................................................................ 7	
1.2.1	 Principles and different phage display modes .......................................... 7	
1.3	 Phage display: Screening random phage-displayed peptide library against 
biological systems - Biopanning .................................................................. 10	
1.3.1	 The construction of a phage library ........................................................ 10	
1.3.2	 Biopanning on live cells – Cell Panning ................................................ 11	
1.3.3	 The basic procedure of in vitro cell panning/in vivo panninng .............. 11	
1.3.4	 Identified peptide motifs using phage screening against mammalian cells 
and tissues ............................................................................................... 14	
1.4	 Limitation on the peptides to be displayed ...................................................... 18	
1.5	 Applications ..................................................................................................... 19	
1.5.1	 Phage as a template to synthesize and assemble nanoparticles .............. 19	
1.5.2	 Bone Regeneration ................................................................................. 20	
vi 
1.5.3	 Proteomic analysis (Ligand-receptor/Antibody-antigen interaction) ..... 22	
1.5.4	 Custom diagnostics and targeted therapy ............................................... 23	
Chapter 2:	 Oriented Nucleation of Hydroxylapatite Crystals on Self-assembled 
Bacteriophage Bundles ....................................................................................... 26	
2.1	 Introduction ..................................................................................................... 26	
2.2	 Materials and Methods .................................................................................... 30	
2.2.1	 Reagents. ................................................................................................ 30	
2.2.2	 Molecular cloning of M13 bacteriophage PVIII display. ....................... 30	
2.2.3	 The production, amplification, and purification of engineered phage. .. 31	
2.2.4	 The preparation of HAP supersaturated solution. .................................. 32	
2.2.5	 Nucleation of phages in HAP supersaturated solution. .......................... 32	
2.2.6	 Ultraviolet (UV) Absorption and Circular Dichroism (CD) spectroscopy.
 ................................................................................................................ 32	
2.2.7	 Transmission Electron Microscopy Characterization. ........................... 33	
2.3	 Results and Discussions .................................................................................. 33	
2.4	 Conclusions ..................................................................................................... 44	
Chapter 3:	 Bacteriophage-Gold Nanocomposites As a Model to Study Transmission 
Electron Microscopy of bioinorganic nanohybrids ............................................ 45	
3.1	 INTRODUCTION ........................................................................................... 45	
3.2	 Materials and Methods .................................................................................... 48	
3.2.1	 Materials ................................................................................................. 48	
3.2.2	 M13 Amplification ................................................................................. 49	
3.2.3	 Synthesis of Gold Nanoparticles ............................................................ 50	
vii 
3.2.4	 Preparation of Phage-Gold Nanoparticle Hybrid ................................... 50	
3.2.5	 Negative Staining ................................................................................... 50	
3.2.6	 Pre-fixation with 1% Glutaraldehyde (GA) ........................................... 51	
3.3	 Results ............................................................................................................. 51	
3.3.1	 Preparation of Gold Nanoparticles. ........................................................ 51	
3.3.2	 Wild-Type M13 Bacteriophage. ............................................................. 52	
3.3.3	 Gold Nanoparticle-Phage Hybrids. ........................................................ 53	
3.3.4	 Best Negative Staining Conditions. ........................................................ 53	
3.3.5	 Choice of Stains. ..................................................................................... 57	
3.3.6	 Choice of the Concentrations of the Stain. ............................................. 58	
3.3.7	 Staining Time. ........................................................................................ 61	
3.3.8	 pH of the Stain. ....................................................................................... 61	
3.3.9	 Drying Method. ...................................................................................... 62	
3.3.10	 Choice of Pre-fixation. ........................................................................... 63	
3.4	 Discussion ........................................................................................................ 63	
3.4.1	 Mechanism of Negative Staining with UA and PTA. ............................ 63	
3.4.2	 Bio-Inorganic Nanohybrids and Negative Staining. .............................. 64	
3.4.3	 Choice of Stain and Working pH Based on Specific Bio-Inorganic 
Nanohybrids. .......................................................................................... 66	
3.4.4	 Choice of Stain Concentration Based on Specific Bio-Inorganic 
Nanohybrids. .......................................................................................... 68	
3.4.5	 Choice of Fixation Based on Specific Bio-Inorganic Nanohybrids ....... 69	
3.4.6	 Why Rapid Drying is better .................................................................... 69	
viii 
3.5	 Conclusion ....................................................................................................... 70	
Chapter 4:	 A novel stem cell binding motif identified by phage display promotes non-
viral gene delivery to stem cells ......................................................................... 71	
4.1	 Introduction ..................................................................................................... 71	
4.2	 Experimental Procedure .................................................................................. 74	
4.2.1	 Materials ................................................................................................. 74	
4.2.2	 Primary rat mesenchymal stem cell isolation and culture ...................... 74	
4.2.3	 Selection of rMSC-binding peptide from a phage-displayed random 
peptide library: Biopanning .................................................................... 75	
4.2.4	 Phage titering, amplification and purification ........................................ 77	
4.2.5	 Statistical Analysis ................................................................................. 78	
4.2.6	 Fluorescence imaging using synthetic peptide ....................................... 78	
4.2.7	 The construction of Liposome/Protamine/DNA complex (LPD) .......... 79	
4.2.8	 Transfection Efficiency .......................................................................... 80	
4.2.9	 Cytotoxicity Assay ................................................................................. 80	
4.3	 Results ............................................................................................................. 81	
4.3.1	 Identification of peptides that can specifically bind with primary rMSCs 
by phage display ..................................................................................... 81	
4.3.2	 Bioinformatics analysis suggests that CX3CL1-CX3CR1 axis may 
mediate binding between the identified peptide, HMGMTK, and rMSCs.
 ................................................................................................................ 88	
4.3.3	 Synthetic peptide HMGMTK showed higher binding affinity to primary 
rMSCs compared to scrambled peptide as control and its affinity binding 
ix 
could be competitively inhibited by engineered phages displaying 
HMGMTK peptide ................................................................................. 92	
4.3.4	 Integrating MSC-binding peptide HMGMTK and NLS peptide into 
Liposome/Protamine/DNA (LPD) nanocomplex showed increased 
transfection Efficiency but remain low cytotoxicity .............................. 93	
4.4	 Discussion ........................................................................................................ 97	
4.4.1	 Peptide HMGMTK may serve as CX3CL1-like ligand and bind to 
CX3CR1 which may narrow the putative binding site region of CX3CL1
 .............................................................................................................. 101	
4.4.2	 MSC binding peptide HMGMTK may serve as a binding motif and 
agonist of CX3CR1 for facilitating the systemic delivery of gene or drug 
to MSCs via receptor mediated endocytosis and improving the use of 
MSCs in the field of cell therapy and regenerative medicine .............. 103	
4.5	 Conclusion ..................................................................................................... 105	
Chapter 5:	 Summary of Results and Future Directions ............................................. 106	
5.1	 Summary of results ........................................................................................ 106	
5.2	 Outlook and future directions ........................................................................ 108	
5.2.1	 Tissue engineering for bone regeneration ............................................ 108	
5.2.2	 Proteomic analysis (Ligand-receptor/Antibody-antigen interaction) ... 109	
5.2.3	 Customized diagnosis and targeted therapy ......................................... 110	
Chapter 6:	 References ................................................................................................ 112	
[Appendix A:  Permissions and Copyrights] ................................................................ 130	
x 
[Appendix B:  Copy of Approval from Institutional Animal Care and Use Committee 
(IACUC)] .......................................................................................................... 143	
xi 
List of Tables 
Table 1-1 The coat proteins on one M13 bacteriophage and their functions ................... 4 
Table 1-2 Identified peptide motifs using phage screening against mammalian cells and 
tissues. ............................................................................................................................ 17 
Table 3-1  A summary of conditions interrupting the association of Au-NPs and phage 
with justification. ............................................................................................................ 66 
Table 4-1  Peptide sequences identified by phage display. Homological motifs were 
underlined and the most frequent one (A/H)MG(M/L)(T/L/S/R)(K/T/S) were also 
highlighted in bold. ......................................................................................................... 87 
Table 4-2  The cell surface molecular profile of mesenchymal stem cells .................... 89 
 
xii 
List of Figures 
Figure 1-1 Schematic structure of the filamentous bacteriophage ................................... 3	
Figure 1-2 3D structure of one M13 phage (PDB:1ifd) and its top view and bottom view. 
Crystal structure of pVIII which can be divided into four portions: a mobile segment 
colored in dark blue, an amphipatic helix in bright blue, and a highly hydrophobic helix 
in yellow, and another amphipatic helix in pink but with four positively charged amino 
acids in red which are responsible for binding negatively charged DNA phosphate 
backbone. .......................................................................................................................... 6	
Figure 1-3   A sketch of Phage life cycle ......................................................................... 7	
Figure 1-4 Different types of phage display based on different types of coat proteins.[9]
 .......................................................................................................................................... 8	
Figure 1-5 Basic procedure of phage library screening on biological systems. A) In vitro 
cell panning; B) In vivo panning against live animals. .................................................. 13	
Figure 1-6 Bone formation in natural bone .................................................................... 21	
Figure 1-7   Scheme of phage display applied in the fabrication of bone materials ...... 22	
Figure 2-1  Phage display technique. a) TEM images of wild type M13 phages. b) 
Display of a foreign peptide on the side wall of M13 phage by fusing the peptide to the 
N-terminus of pVIII. c) 3D model of M13 phage pVIII protein coat (PDB id: 1ifd). ... 30	
Figure 2-2. TEM images of engineered phages. a) E phages; b) Q phage bundles; c) 
mixed EQ phage bundles. d) Circular dichroism spectra of wildtype, E, Q and EQ 
phages. ............................................................................................................................ 35	
Figure 2-3  TEM images of nucleation of HAP on E and Q phages after incubation in 
supersaturated HAP solution for 10 days and 20 days. a) HAP nucleation on E phages 
xiii 
for 10 days. b) HAP nucleation on E phages for 20 days. c) HAP nucleation on Q 
phages for 10 days. d) HAP nucleation on Q phages for 20 days. ................................. 37	
Figure 2-4  TEM images of the HAP nucleation on EQ phage bundles after incubation 
for: a) 5 days, b) 10 days, c) 15 days and d) 20 days. .................................................... 39	
Figure 2-5 The three dimensional simulation of possible HAP nucleation mechanism. a) 
3D model of possible EQ phage bundles. b) The simulation of intermolecular beta sheet 
formed by two HAP nucleating peptides displayed on phage pVIII. This model includes 
the aspartic acid (D) which is the following amino acid right after the inserted foreign 
peptides in pVIII due to its possible contribution to the beta sheet formation. c) 
describes the possible mechanism of the HAP nucleation and growth along c-axis due to 
the specific match between the negatively charged amino acid in HAP nucleating 
peptides forming intermolecular beta sheet and the (001) plane of HAP crystals. d) 
shows the four calcium ions on HAP (001) plane that can perfectly match four 
negatively charged amino acids. e) is a closer look of electrostatic attraction between 
matched negatively charged amino acids and calcium ions. f) is the 3D model which 
schematically illustrates the possible mechanism of HAP crystal nucleation and oriented 
growth triggered by EQ phage bundles. ......................................................................... 43	
Figure 3-1  a) M13 wild type phage particles composed of ~2700 copies of major coat 
proteins (pVIII) and 5 copies of each minor coat protein (including pIII, pVI, pVII, and 
pIX); b) Positively charged Au-NPs interacted with anionic phage particles into bundle 
structures. ........................................................................................................................ 48	
xiv 
Figure 3-2  a) Synthesized gold nanoparticles and the electron diffraction pattern; b) 
wild type M13 phages stained with 1% UA; c) gold-nanoparticle-phage hybrids 
precipitation; d) TEM image of the hybrid precipitation from c. ................................... 55	
Figure 3-3  Comparison of Figure 3-2d and Figure 3-4b. Au-NPs in Figure 3-4b are 
highlighted by red circles. The density of Au-NPs on the hybrids after negative staining 
is almost the same as without staining. .......................................................................... 56	
Figure 3-4 a) Au-NP-phage hybrids were stained with 0.5% UA solution (pH=4.5, 10 s 
of staining, rapid drying); b) high resolution image of a); c) Au-NP-phage hybrids were 
stained with 0.5% PTA solution (pH=7, 10s of staining, rapid drying); d) high 
resolution image of c). .................................................................................................... 57	
Figure 3-5  a) Au-NP-phage hybrids were stained with 2% UA solution (pH=4.5, 10s of 
staining, rapid drying); b) Au-NP-phage hybrids were stained with 0.5% UA solution 
(pH=4.5, 1 minute of staining, rapid drying); c) high resolution image of b); d) Au-NP-
phage hybrids were stained with 0.5% UA solution (pH=3.5, 10s of staining, rapid 
drying); e) Au-NP-phage hybrids were stained with 0.5% UA solution (pH=4.5, 10s of 
staining, slow drying); f) Au-NP-phage hybrids were pre-fixed by 1% GA solution and 
stained with 0.5% UA solution (pH=3.5, 1 minute of staining, slow drying). ............... 60	
Figure 4-1 Scheme of applying phage display and mesenchymal stem cells to 
customized therapy. ........................................................................................................ 73	
Figure 4-2 Recovery of phages after affinity selection on primary rat MSCs (O/I ratio)
 ........................................................................................................................................ 82	
Figure 4-3  Plot of the information content of peptide sequences calculated by RELIC-
INFO program. RELIC-INFO program was used to measure the probability of a peptide 
xv 
sequence by random selection or by affinity selection. In this program, the probability 
of any one peptide in the library is defined by a parameter called Information content= - 
ln (P) where P is the product of the probability of each amino acid at each position, 
a.k.a. P = P1P2P3•••P12. The red curve with round dots is the information content of 
selected sequences from affinity selection on rMSC. The black curve with square dots is 
the information content of originally random Ph.D.-12 library sequences used as 
control. The dark blue dash line shows the cutoff indicating significant improvement of 
the reliability of selected sequences compared to random library sequences. ............... 85	
Figure 4-4  The similarity score of reliable selected sequences and several known 
ligands that interact with both MSC positive and negative surface receptor. Stro-1, 
SB10, CX3CL1, SDF-1, CXCL16, ICAM-1, VCAM-1, fibronectin are the known 
ligands that could bind to the MSC expressed cell surface receptors (MSC+). LYN and 
CCL11 are two examples of known ligands binding the receptors that MSCs could not 
express (MSC-). A cutoff value 10 was set for indicating the significant similarity by 
arrows. ............................................................................................................................ 91	
Figure 4-5  Best match position in the full length CX3CL1 with reliable selected 
sequences aligned by RELIC-MATCH program. This match position in CX3CL1 is 
localized in its N-terminal chemokine domain (CX3CL1-CD) which may suggests the 
exact binding site of CX3CL1. ....................................................................................... 91	
Figure 4-6  The fluorescence imaging showing the higher affinity of peptide HMGMTK 
compared to scrambled peptide as control. A) rMSCs after interacted with FITC-
HMGMTK peptide; B) rMSCs after interacted with FITC-scrambled control peptide; C) 
rMSCs after treated with phage displaying HMGMTK first and then interacted with 
xvi 
FITC-HMGMTK peptide; D) rMSCs after treated with phage displaying HMGMTK 
first and then interacted with FITC-scrambled peptide. E) fibroblasts incubated with 
FITC-HMGMTK peptide; F) MCF-7 cells incubated with FITC-scrambled peptide. Cell 
nucleus was stained by DAPI. Scale bars in A, B, C, and D are 50µm and in E and F are 
100µm. ............................................................................................................................ 93	
Figure 4-7  TEM image of LPD particles. ...................................................................... 94	
Figure 4-8   Transfection efficiency of LPD with peptide HMGMTK and NLS peptide 
in rMSC. GFP expression level in rMSCs due to the delivery of EGFP reporter gene by 
LPD only (a) and LPD+PA+NLS (b) was visualized by fluorescence imaging. Scale 
bar: 100 µm. .................................................................................................................... 95	
Figure 4-9  MTT assay for evaluating cytotoxicity of LPD+PA+NLS at different 
liposome concentrations. LipofectamineTM 2000 and LPD without peptide were used as 
a control. The cell viability of samples with LPD with PA and NLS above liposome 
concentrations 50mM was higher than 60%. LipofectamineTM 2000 had obvious 
toxicity as concentrations over 20 mM. The data points represent the mean ±SD of three 
trials. ............................................................................................................................... 96	
Figure 4-10   The tertiary structure of chemokine domain of CX3CL1. It consists of a 
flexible N-terminal region three beta strands (in yellow), and a C-terminal helix (in red). 






Nanostructure is an object system that has dimensions on the nanoscale, i.e. 
between 0.1 and 100 nanometers. It includes nanotextured surface, nanotube, nanorod, 
nanofilament, nanoparticle, etc. The field of nanostructure science and technology is an 
explosively growing area in the past decades. Its tremendous potential for innovating 
the material science (referred as nanotechnology) and promising applications in the 
conjugation with current medicine (referred as nanomedicine) to preserve and improve 
human health is already clear, though the understanding of nanostructure functionalities 
is just beginning to reveal. Nanostructures can be considered as novel rising objects in 
the scientific community. However, to biologists, nanostructures are familiar since even 
the simplest organism contains astoundingly sophisticated elements functionalizing at 
the nanoscale which are still difficult even under the most advanced technologies, such 
as protein folding, formation of protein aggregates, pairing of nucleotides, and precise 
assembly of microbes.  
Filamentous bacteriophage, the subject of this dissertation, is a representative 
instance of naturally biological nanostructures. Using standard molecular cloning 
technique, foreign peptides can be fused into the phage protein on the surface, termed as 
Phage Display technique. Although phage display has primarily been used for studying 
protein-protein interactions, it has two main research directions in the area of 
nanotechnology by using two different aspects of phage. The filamentous shape of the 
phage in the nano range provides the bio-template function of phages used within 
nanotechnology and material science while phage display can also provide an easy way 
to discover new targeting motifs, drugs or epitopes for medical applications. Both 
xviii 
methods are becoming more popular, but the possibility of identifying targeting 
peptides against live cells and intact tissues including tumors greatly increases the 
potential application of using phage display in the biomedical field. My research 
followed the two main research directions of phage display in nanotechnology. I also 
focused on the uses and advances of phage display in the biomedical field.  
Chapter 2 is the application of phage as a bio-template for bone regeneration: 
Oriented nucleation of hydroxylapatite crystals on self-assembled bacteriophage 
bundles. This work demonstrates the hydroxyapatite crystals can be nucleated on self-
assembled bacteriophages in a preferred c-axis orientation. The resultant bacteriophage 
may serve as the building block to substitute collagen and form bone implant. It has a 
great potential in the field of tissue engineering. It also proved that the driving force of 
phage self-assembly is beta sheet secondary structure and beta sheet between phage 
bundles can induce the orientated nucleation of hydroxyapatite crystals.  The beta sheet 
formation can be used as a general method to precisely control assemblies between 
engineerable biomaterials. In natural bone, HAP crystals are nucleated and grown with 
their c-axis preferentially parallel to collagen fibrils. In the work of Chapter 2, we also 
found that HAP crystals were also nucleated on EQ bundles with their c-axis 
preferentially parallel to phage bundles, which greatly mimicked the base level of 
hierarchical structure of natural bone. We further found that calcium ions were attracted 
to the glutamic acids and aspartic acids of peptide E and Q with a pattern matching with 
calcium ions on the (001) plane of HAP crystals. This specific matching then induced 
the HAP nucleation on the beta sheet and the growth along the c-axis. This work 
xix 
provided the proof for a new way of fabricating bone biomaterials by biomimicking and 
bioinspiration. 
Chapter 3 is the phage as a bio-template for the synthesis of phage-gold 
nanocomposites. Bacteriophage-gold nanocomposite was constructed in the work of 
Chapter 3 to use as a model to study the optimum condition for best TEM imaging of 
bioinorganic nanohybrids. In this work, wild type M13 phage was combined with gold 
nanoparticles to form phage-gold nanocomposite. Most Au-NPs were aligned into large 
belts, forming a net-like structure. TEM imaging of negatively stained bioinorganic 
nanohybrids is a simple way to characterize these nanostructures that may have 
biomedical functions. By studying the effects of different factors on the negative 
staining of phage-gold nanocomposites, we found that the optimum staining conditions 
for these bioinorganic nanohybrids are using 0.5% UA solution with pH 4.5, staining 
for 10 seconds, and rapidly drying the stains. This work demonstrates that each staining 
factor has an influence to the final appearance of stained specimens and optimum 
staining condition needs to be customized to the individual type of bioinorganic 
nanohybrids. The effects of each staining factor and a general guideline for selecting 
staining condition were provided in this work. Therefore, this research provides useful 
information for the characterization of bioinorganic nanomaterials by TEM imaging. It 
will help the research in the field of nanomaterials and bionanotechnology. 
Chapter 4 is discovering a novel targeting motif to mesenchymal stem cells by 
phage display to improve the efficiency and specificity of gene or drug delivery. In this 
work, we did cell panning on primary mesenchymal stem cells and identified peptide 
HMGMTK as MSC binding peptide. Further bioinformatics analysis suggests that 
xx 
peptide HMGMTK has high similarity to the signaling regions of chemokine CX3CL1. 
This may suggest a possible mechanism that could explain the MSC homing effect of 
the selected peptide. We then constructed a novel and effective mesenchymal stem cell 
gene delivery vector by liposome/protamine/DNA complex incorporating with 
identified MSC-targeting motif and Nuclear localized signal (NLS) motif. Through 
several evaluations, we proved that this resultant complex is multifunctional, effective, 
but low-cytotoxic MSC gene delivery vector. The transfection mediated by the resultant 
complex LPD+PA+NLS showed higher efficiency and specificity compared to those 
achieved by LPD only, LPD with control peptide, or LPD with PA only. Meanwhile, 
MTT results supported the low cytotoxicity of LPD+PA+NLS complex. Based on all 
the results, we can conclude that a novel rMSC binding peptide HMGMTK was 
identified and could be used to build up a promising gene carrier for facilitating 
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Chapter 1: Introduction 
2010 is the 25th anniversary of phage display since George Smith first 
introduced it in 1985 [1]. Phage display is a term defining fusion of exogenous peptide 
sequences onto the capsid proteins of filamentous bacteriophages. The subject of phage 
display is filamentous bacteriophage (simply phage) including M13, Fd phage, etc.[2]. 
Phage is a linear-shaped type of virus that specifically infects gram-negative bacteria, 
such as Escherichia coli (E. coli) TG1, XL-1 Blue, ER2738. In phage display, different 
foreign peptide sequence variants (up to 1010 diversity) could be expressed or displayed 
on the surface of the phage concurrently by designing randomized primers during 
genetic engineering rather than having to express and purify peptide sequence one after 
another in the traditional recombinant protein expression. The resultant phage display 
product displaying various peptide sequences is visually termed as “phage library”. 
Coupled with affinity selection process (known as panning), phage library renders the 
feasibility of rapid and efficient identification of acting or signalling regions of proteins 
or peptides with high affinity and specificity to most targets, including molecules in 
vitro, living cells, human or animal tissues and even human tumor patients. This is the 
most valuable aspect of phage technology since no pre-attentive knowledge about the 
interaction is necessary.  
In this chapter, I will provide the basics of bacteriophage: the biology and 
structure of bacteriophage. I will explain the principles of phage display technique. A 
detailed explanation will be given to the phage display-based peptide screening against 
cells in vitro and tissues in vivo. I will then introduce the applications of phage display 
in nanotechnology and biomedical science. Further attention will be on the application 
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of the identified cell/tissue-targeting peptides for improving biomedical research and in 
the novel design of a therapeutic strategy to overcome barriers in traditional drugs or 
clinical treatments.  
1.1 Filamentous Bacteriophage Biology 
1.1.1 Phage structure as a biological nanorod 
Filamentous bacteriophage is a rod-shaped type of viruses that usually infects 
Gram-negative bacteria and its main type is Ff phages. The Ff class of filamentous 
bacteriophages includes M13, fd, f1, and lke phages possessing 98% identical DNA 
sequences, though M13 is the most studied type [2].  
Till now, there are two main research directions in which filamentous 
bacteriophages are investigated by utilizing different properties of phages. First, Ff 
phages are nonlytic and parasitic viruses, which means that infection and production of 
Ff phages will give rise to progeny virus extruded out of the bacterial membranes 
without causing host death, but rather leaving the infected cells continuing to grow and 
proliferate. This parasitic nature of Ff phage becomes one of the reasons that made the 
filamentous bacteriophage, especially M13 phage, become an efficacious workshop for 
expressing protein or peptide of interest; while little limitation of inserted DNA and the 
superbly high viral productivity are the other two reasons. Second, the Ff phages are in 
nanometric dimensions, about 1 µm in length and 6 nm in width, which could fit into 
the definition of nanostructures and thus can be adapted into the exploitation of nano-
bio-technological use, together with other biological molecules, such as DNA, actin 
filament or amyloid fibrils (Figure 1-1). As biological nanorods, filamentous 
  3 
 
bacteriophages can provide the scientists a natural biotemplate for nanomaterial 
synthesis.  
 
Figure 1-1 Schematic structure of the filamentous bacteriophage 
 
Wild type M13 phages consist of a circular single-stranded DNA (ssDNA) with 
6407 bases surrounded by 2700 copies of the major coat protein pVIII. Five copies of 
four different types of minor coat protein are on both of the ends: pIII and pVI cap one 
end, while pVII and pIX cap on the other one. These five types of coat protein together 
are categorized as structural protein since they are expressed on the surface of phages to 
form the final intact phage structure, while the other six types of protein are only 
involved in the infection and replication process of phages as non-structural proteins 
(Table 1-1). Among five structural proteins, pVIII occupies the majority of phage in 
mass, about 85%. The high amount of pVIII present on one phage particle makes it 
become a productive candidate for foreign protein expression on phages, though pIII is 
the first coat protein that studied for this purpose.  
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Table 1-1 The coat proteins on one M13 bacteriophage and their functions 
 
pIII is the largest and most complex protein among all the phage proteins. It is 
responsible for recognizing the host cell surface via F-pilus and therefore infecting the 
host. Details will be introduced in the next section: phage life cycle. It has three 
domains, N1, N2 and N3; the two N-terminal segments N1 and N2 are believed to be 
somewhat flexible at the end of phage to do host infection, while the C-terminal N3 
domain is interacted with pVIII and thus associated into the phage particle. The 
association is first formed by the N-terminal domains N1 and N2 of pIII with F-pili of 
male E. coli hosts; during the infection it is shifted to the complex of N1 and the C-
terminal domain of Tol-A protein as a co-receptor in the Tol-QRA complex within the 
inner membrane of bacterial cells while N2 is still associated with F-pili [3]. This is 
Categories Protein name 
# of amino 







pIII 406 42,522 5 Host infection 
pVI 112 12,342 5 Minor coat protein 
pVIII 50 5,235 2700 Major coat protein 
pVII 33 3,599 5 Minor coat protein 









pI 348 39,502  Assembly 
pII 410 46,137  DNA replication 
pIV 405 43,476  Viral assembly 
pV 87 9,682  Binding ssDNA 
pX 111 12,672  DNA replication 
pXI 108 12,424  Viral assembly 
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responsible for recognizing the host cell surface via attaching F-pilus of male E. coli to 
initiate the infection process. 
The major coat proteins pVIII are arranged in a right-handed helical pattern with 
a fivefold rotational axis and a twofold screw axis with a pitch of about 3.2 nm to form 
a 1.5-2 nm thick protein coating around single-stranded DNA. Each of pVIII is alpha 
helical and can be divided into four portions from N-terimus to C-terminus: a mobile 
segment having 4 or 5 amino acids, an amphipathic helix portion, a highly hydrophobic 
helix portion, and another amphipathic helix portion with four positively charged amino 
acids for interacting with negatively charged phosphate backbone of ssDNA (Figure 
1-2).   




Figure 1-2 3D structure of one M13 phage (PDB:1ifd) and its top view and bottom 
view. Crystal structure of pVIII which can be divided into four portions: a mobile 
segment colored in dark blue, an amphipatic helix in bright blue, and a highly 
hydrophobic helix in yellow, and another amphipatic helix in pink but with four 
positively charged amino acids in red which are responsible for binding negatively 
charged DNA phosphate backbone. 
 
1.1.2 Phage Life Cycle 
The life cycle of filamentous bacteriophage can be divided into three stages: 
infection, replication, and assembly (Figure 1-3). During filamentous phage infection, 
the virus first binds to its primary receptor – the tip of the F-pilus inserted on bacterial 
cell surface, followed by the phage coat protein integrating into the bacterial cell 
membrane, so that the viral ssDNA injected into host cell cytoplasm to enter the 
replication stage.  pII and pX, two of non-structural proteins, are crucial for the 
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replication. pII has both endonuclease and topoisomerase activities required during the 
DNA replication phase of infection.   
 
Figure 1-3   A sketch of Phage life cycle 
 
1.2 Phage display: displaying a peptide on the surface to change the surface 
chemistry 
1.2.1 Principles and different phage display modes 
The main theme of phage display is to incorporate foreign peptides into the coat 
protein of filamentous bacteriophages. Yet the various types of phage coat protein and 
the necessity of ensuring engineered coat protein still functional as well as the 
biological bottlenecks during phage replication course question the phage display and 
the construction of phage library, making the following three queries: (1) Which types 
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of coat protein are used in phage display? (2) What is the strategy for phage display? (3) 
What is the strategy for constructing phage library? (4) Which foreign protein or 
peptide we could display on phages? Is there any limit for them? 
Years of experiments have led to the successful peptide and protein fusions into 
all the five types of structural coat protein of phage (Figure 1-4): to the N-terminus of 
display on pIII, pVII, pVIII and pIX and on the C-terminus of pVI [4-8]. pIII is the first 
phage coat protein used for fusing foreign peptide. pIII and pVIII display is the most 
common approach so far mainly by reason of their prominent merits which are wider 
tolerance range and stronger productivity, respectively. Wider tolerance range means 
that the larger peptides or proteins could be displayed more easily on pIII and stronger 
productivity describes that displayed peptide or proteins will have greater yield on pVIII 
than other types of protein. Both of them have highly significant value in consideration 
of the essence of phage display that bring pIII and pVIII display into fashion.  
 
Figure 1-4 Different types of phage display based on different types of coat 
proteins.[9] 
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Regardless of the different structural protein types in phage display, the 
strategies for achieving phage display is mainly three types: phage, hybrid and 
phagemid systems termed by Kehoe et al, or type n, nn, and n+n named by Smith et al 
(n represents the type of coat protein used in phage display. For example, n is 3 for pIII 
and 8 for pVIII.) [10, 11]. The different modes of phage display on pVIII are taken for 
instance in order to minimize the possible confusion. The phage system or type 8 is that 
the exogenous protein or peptide to be displayed is fully expressed on each copy of coat 
protein by incorporating the coding gene of displayed peptide into the single stranded 
phage genome. Till now phage system is only obtained positively on pIII and pVIII that 
make types 3 and 8. In hybrid system or type 88, the phage genome is harboring two 
gVIII (coding gene for pVIII): one is the wild type gVIII and the other one is 
recombinant gVIII fused with displayed peptide or protein coding gene; rather than 
having just only recombinant gVIII in the genome as the phage (type 8) system. The 
consequence is that the capsid of phage virions is hybrid which is a mixture of wild type 
and recombinant pVIII. Speaking of phagemid system, it is necessary to explain the 
definition of phagemid. A phagemid is a hybrid of the phage and plasmid which is also 
packaged as ssDNA inside the phage virions. It has both the plasmid origin of 
replication (ori.) which allows its replication in E. coli host and the phage ori. which is 
functional only after the infection by wild type phages termed as helper phage in type 
n+n phage display since the non-structural proteins coded in helper phage genome are 
required for phage replication. Similar to hybrid system (type 88), the capsid of the 
resultant phage virion in phagemid system (type 8+8) is a mixture of wildtype and 
recombinant pVIII.  
  10 
 
1.3 Phage display: Screening random phage-displayed peptide library against 
biological systems - Biopanning 
Since invented in 1985, phage display was further developed and improved by 
many scientists such as John McCafferty [12-14]. Analogous to natural evolutionary 
selection, large libraries of proteins in the phage library could be screened and amplified 
in an affinity selection called phage panning or biopanning. Custom phage libraries 
could be constructed though the commercial phage libraries are already enough for 
identifying a targeting motif to a certain biological target. 
1.3.1 The construction of a phage library 
Besides the different phage display strategy, the genetic engineering method for 
phage display is also diversified, especially for the construction of phage displayed 
libraries. While other methods are also available, such as random mutagenesis including 
in vitro chemical mutagenesis and error-prone PCR, combinatorial infection and 
recombination, and DNA shuffling [15-20], the most commonly used method for this 
purpose is oligonucleotide-directed mutagenesis based on degenerate codons and PCR. 
Degenerate codons can be represented by NNK in which N = A/T/G/C and K = G/T. By 
means of designing the inserted gene of displayed peptide sequence in the format of 
degenerate codon (NNK)n (n is the number of amino acids in the displayed peptide 
sequence.), one will create the DNA source for random displayed peptide library. Since 
there are only 20 possible amino acids available, the DNA encoded peptide diversity is 
restricted to 20n but not 32n which is the coding DNA diversity. For instance, if the 
phage library is displaying 7 mer random peptides, then its theoretical diversity will be 
1.28 ×109 (207) instead of 3.4×1010 (327). After synthesizing the designed mutagenic 
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oligonucleotides as a primer and doing PCR, one needs to incorporate it into an 
appropriate vector and produce the recombinant DNA by ligation. The recombinant 
DNA carrying random mutagenic oligonucleotides will be introduced into a bacterial 
host and eventually produce a phage library displayed random peptides encoded by the 
mutagenic oligonucleotides.  
1.3.2 Biopanning on live cells – Cell Panning 
Originally, phage display was used to screen against the immobilized molecules 
on a plate or matrix by cross-linking. The most common linking reagent is biotin which 
endows the name “biopanning” to this type of phage screening. But the invention of 
direct panning against live cells or tissues or organs [21] broadens the application range 
of phage display, which refers to ‘cell panning’ and ‘in vivo panning’ respectively in 
this dissertation.  
1.3.3 The basic procedure of in vitro cell panning/in vivo panninng 
 In general, the panning procedure for this purpose should be adjusted by adding 
the clearing step and depletion to minimize any nonspecific binding prior to panning 
against the target. The selection against live cells can be done on either adherent or 
suspended cells. Different from cell panning, originally in in vivo panning the library is 
introduced into a living animal through injection, ventilation, or gavage and the bound 
phage is collected from homogenized tissue biopsies.  
The basic procedure of cell panning and in vivo panning can be represented by 
Figure 1-5 involving steps [22-27]:  
(1) Prepare the initial phage library or amplified library from previous 
panning rounds 
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(2) Pre-clear the surface receptors of cells or tissues by incubating with 
serum-free medium 
(3) Deplete the initial library by exposing onto the blank substrate (plastic 
plate) or multiple cell lines (such as cells co-existing with target cells in the 
tissue).   
(4) Expose the depleted library to the pre-cleared target cell or tissue  
(5) Remove any non-specific bound phages by washing 
(6) Elute out the bound phage and amplify them by infecting bacterial hosts. 
(7) Repeat steps 1-6 above several times. 
(8) Identify target motifs by sequencing the output of the final panning 
round. 
 




Figure 1-5 Basic procedure of phage library screening on biological systems. A) In 
vitro cell panning; B) In vivo panning against live animals.  
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1.3.4 Identified peptide motifs using phage screening against mammalian cells 
and tissues 
Recent technical advances allow sufficient data collection from affinity selection 
against multiple tissues and organs, which further ease the phage screening against 
complex biological systems. For instance, the use of phage libraries for identifying 
tumor-targeting peptides has been reviewed in ref. [28-31]. The first clinical trial of 
phage panning on human patients is constructed by Krag et al. [32]. Identifying 
targeting peptides to stem cells has also proved feasible [33]. Table 1-2 lists the 
targeting peptides that have been identified by cell panning and in vivo panning with a 
random peptide-displayed phage library, and those using the scFv and combinatorial 
antibodies libraries are not listed.  
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Targets Sequence Reference 
Cell panning   
Cancer cells   
Human hepatic carcinoma cell ExTie2 NSLSNASEFRAPY [34] 
Human breast cancer cells SKBR3 LTVXPWX,VSSTQDFP,DGSIPWST [35, 36] 
Breast cancer cells MCF-7 DMPGTVLP [37] 
Human neuroblastoma WAC-2 HLQIQPWYPQIS [38] 
Human head and neck squamous cancer 
cells 
TSPLNIHNGQKL [39] 
Melanoma cell B16F10-Nex2 SSRTMHH [40] 
Murine B lymphoma A20. pA20-6 [41] 
Pancreatic ductal adenocarcinoma (PDAC) 
cells 
KTLLPTP [42] 
Esophageal adenocarcinoma cells OE33 CSNFYMPLC [43] 
Prostate carcinoma cells P3 DTDSHVNL,DTPYDLTG,DVVYALSD
D 
[44] 
Non-small cell lung cancer cells QQMHLMSYAPGP;TDSILRSYDWTY [45, 46] 
Human glioma cells LLADTTHHRPWT [47] 
U87MG glioblastoma cell VTWTPQAWFQWV [48] 
Human medullary thyroid carcinoma-
derived TT cells 
HTFEPGV [49] 
Nasopharyngeal carcinoma (NPC) cells RLLDTNRPLLPY [50] 
Epithelial cells   
Human gastric cancer vascular cells CGNSNPKSC [51] 
Human airway epithelial cells THALWHT [52] 
Human airway epithelial cell line  LQHKSMP [53] 
Endothelial cells ECV304 SPL(W/F)(R/K)(N/H)S(V/H)L 
YCPRYVRRKLENELLVL 
[54, 55] 
Lung endothelial cells CGSPGWVRC [56] 
Human blood outgrowth endothelial cells 
(HBOEC) 
SPTPS(P/L)PPSAGG [57] 
Human Vascular Endothelial Cells SIGYPLP [58] 
Vascular smooth muscle cells (VSMC) CESLWGGLMWTIGLSDC 
CNIWGVVlSWIGVFPEC 
[59] 
Vascular Smooth Muscle Cells EYHHYNK 
GETRAPL 
[60] 
Murine myofibers ASSLNIA [61] 
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Primary cardiomyocytes WLSEAGPVVTVRALRGTGSW [62] 
Cardiac vasculature cells DDTRHWG [63] 
TNF-α activated bovine aortic endothelial 
cells  
CLWTVGGGC [64] 
Stem cells   
Mouse neural stem cells C17.2 CGLPYSSVC [33] 
Monkey neural stem cells HGEVPRFHAVH [65] 
Mouse embryonic stem cells KHMHWHPPALNT [66] 
Rhesus monkey embryonic stem cells  
RS366.4 
APWHLSSQYSRT [67] 
Other types of cells   
Dendritic cells (DC) YTYQGKL [68] 
Human dendritic cells FYPSYHSTPQRP,AYYKTASLAPAE,S
LSLLTMPGNAS 
[69] 
Rat malignant rat glial cells D(T/S/L)TK motif [70] 
Murine microglial cells EOC20 (S/T)F(T/X)YWS [71] 
Mouse PEA10 fibroblasts KTLTLEAALRNAWLREVGLK [72] 
S100A4 knockout embryonic fibroblasts F⁄YCC motif [73] 
Human colorectal cells WiDr HEWSYLAPYPWF [74] 




CTGKSC, PAVLG, LRVG 
[75-77] 
Plasmodium falciparum-infected red blood 
cells  
LVDAAAL [78] 
Skin langerhans cells (LCs)  GPEDTSRAPENQQKTFHRRW [79] 
Human papilloma viruses (HPVs) 
transformed cells 
C(R/Q)(L/R)T(G/N)XXG(A/V)GC [80] 
Human Sperm XLWLLXXG [81] 
Human umbilical cords KPSGLTY [82] 
Human and rabbit synovial cells SFHQFARATLAS [83] 
Hyaluronan on cell surfaces GAHWQFNALTVR [84] 
   
In vivo panning   
Human medullary thyroid carcinoma SRESPHP [85] 
Mouse mammary tumor RLQLKL,RTRYED,RIPLEM,QFDEPR,T
SAVRT 
[86] 
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Table 1-2 Identified peptide motifs using phage screening against mammalian cells and 
tissues.   
Sprague-Dawley rat islets LSGTPERSGQAVKVKLKAIP [87] 
PPC-1 human prostate carcinoma xenograft 
tumors 
R/KXXR/K [88] 
Rat transient middle cerebral artery 
occlusion model 
CLEVSRKNC [89] 
Mice oral cancer xenografts SNPFSKPYGLTV, YPHYSLPGSSTL [90] 









Mouse lung CGFECVRQCPERC [93] 
Mouse skin CVALCREACGEGC [93] 
Mouse retina CSCFRDVCC [93] 
Mouse pancreas SWCEPGWCR [93] 
Mouse brain CSSRLDAC [21] 
Mouse kidney CLPVASC [21] 
Mouse placenta TPKTSVT [94] 
Mouse fat CKGGRAKDC [94] 
Abdominal skin of BALB/cA nude mice ACSSSPSKHCG [95] 
Rat kidney  HTTHREP, HITSLLS [96] 




Synovium  CKSTHDRLC [100] 
Atherosclerotic Lesion Surfaces CAPGPSKSC [101] 
Murine pancreas langerhan islet CVSNPRWKC, CHVLWSTRC [102] 
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1.4 Limitation on the peptides to be displayed 
All the three paragraphs above answer three questions out of four in the 
beginning of this part, one per question. Subsequently in the last but not the least, the 
limitation in the displayed foreign peptides of phage display will be given an account of 
to the researchers dealing with phage work. Pondering over the protein synthesis and 
secretion process in the phage replication cycle, one would not be surprised that the 
main restriction of displayed peptides in phage display is imposed by the peptide size 
and amino acid preference during the protein insertion in the host bacterial inner 
membrane and protein processing for phage assembly. It is well established that excess 
basic amino acids in the displayed sequence harm its transport and insertion in the cell 
membrane due to the proton motive force (pmf) induced by extra positive charges [103-
106]. Besides, cysteine residue of displayed peptide in odd number may facilitate the 
dimerization by intermolecular disulfide bonds formed between unpaired cysteine 
residues in displayed peptide and native pIII cysteine residue or between two displayed 
peptides on pVIII when they are inserting in the cell inner membrane [106, 107]. This 
spontaneous dimerization may interfere the infection by pIII or hinder the pVIII 
secretion and assembly as the ssDNA extruded out to form phage progeny. The study 
found that the cyclic disulfide rings have strong preference for the recombinant phage 
clones [107]. In addition, Rodi et al. also observed an overall under-abundance of 
arginine and glycine besides cysteine and an over-abundance of proline, threonine and 
histidine residues as well as three position-dependent amino acid bias on +1, +3, +12 
downstream from the signal peptidase cleavage site in the 12-mer library [106]. 
Therefore, we can conclude that the actual peptide diversity of libraries (functional 
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diversity) is much lower than the theoretical one (technical diversity). Rodi et al. have 
also defined the functional diversity in the equation: diversity = d = 1 20! 𝑝!!! , 
where N is the number of amino acids in the random peptide sequence, 𝑝! is the 
probability of 𝑘th sequence selected from the random peptide library.  
 
1.5 Applications 
1.5.1 Phage as a template to synthesize and assemble nanoparticles 
The assembly of nanomaterials into ordered hierarchical structures is a very 
important step towards the fabrication of supramolecular structures and nanodevices. A 
promising strategy is to employ well-defined nano-scale structures as templates to direct 
the assembly of nanomaterials. Till now, a wide variety of self-ordered nanostructures 
as templates has been studied. One important branch of these templates is refined 
biomolecules that are naturally occurred, including nucleic acids, proteins, viruses [108-
111]. These natural biomolecules all have sophisticated hierarchical nanostructures with 
precise molecular recognition. Guiding the formation of functional inorganic 
nanomaterials with these biomolecules has led to many nanostructures with controlled 
size, shape, alignment, and orientation.  
Filamentous bacteriophages, the subject of this research, have well-defined 
nanostructures, the genetically programmable surface chemistry, and excellent stability. 
All these properties are attractive to material scientists for using as template to fabricate 
nanomaterials.  
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1.5.2 Bone Regeneration 
Numerous reasons can cause bone loss and thus require bone repair, including 
traumatic injury, bone cancer, birth defects. The traditional treatment is to implant 
natural bone graft from the patients into the injured area. However, due to its limited 
supply and patient pain, in recent years scientists are turning to seek a substitute for 
bone implants by mimicking natural bone structure.  
In natural bone, collagen molecules are first self-assembled into collagen fibrils 
and then served as template to nucleate HAP by absorbing calcium, phosphate, and 
hydroxide ions from our body fluid (Figure 1-6).  The growth of HAP on collagen 
fibrils has an orientation preference. It will grow along its c-axis, a.k.a. <001>, parallel 
to the collagen fibrils. Although collagen is the dominant protein in bone, it has been 
proved that they are not greatly involved in the crystallographic control over HAP 
nucleation and growth. It is the non-collagenous proteins such as dentin matrix protein-
1 (DMP-1) that manipulate HAP nucleation and oriented growth. After this, osteoblast, 
also called bone-forming cells, will attach and grow on these mineralized collagen 
fibrils and finally assemble into intact bone. Osteoblast is derived from mesenchymal 
stem cells found in bone marrows. 




Figure 1-6 Bone formation in natural bone 
 
There are three characteristics inherent to natural bone: osteoconductivity, 
osteogenicity, and osteoinductivity. An ideal bone material should be similar to natural 
bone and have all three properties (Figure 1-7). Osteoconductivity means the materials 
should have the ability to serve as a scaffold to support new bone formation and growth. 
Osteogenicity indicates the presence of osteoblasts or mesenchymal stem cells which 
can differentiate into osteoblasts. Osteoinducitivity means the material can promote new 
bone formation and growth with the presence of non-collagenous proteins that induce 
HAP nucleation.  
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Figure 1-7   Scheme of phage display applied in the fabrication of bone materials 
 
 
1.5.3 Proteomic analysis (Ligand-receptor/Antibody-antigen interaction) 
Proteomics is the study of proteins in the aspects of their structures and 
functions. It is an analog to genomics, the study of genes. Scientists are more interested 
in proteomics than genomics because genomics itself could not provide understanding 
of biological functions of all proteins as good as proteomics does. The genomic study 
may be limited by the level of transcription, post-translational modification, alternative 
splicing and conformational requirement. Therefore proteomics made researchers be 
able to study gene expression profiles at the protein level by complementing genomics. 
However, proteomics requires analyzing techniques, such as phage display technique, 
that could study small or specific populations of proteins in naïve or diseased conditions 
so that it could accurately reveal the protein characteristics [112, 113]. By using phage 
display as a screening system, receptors can be screened in their native conformation 
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which allows the unbiased identification of ligand-like peptides and the proteome 
mapping by combining the phage screening with the bioinformatics and further assays. 
One of the advantages of applying phage library is that the antibodies or ligands 
could be selected and amplified by a process similar to natural selection occurring in 
living organism. Moreover, membrane proteins are one of the challenges in proteomics 
analysis because of their low abundance and poor solubility, though they are major drug 
targets. Panning on intact cells provides a direct and trustable path to identify antibodies 
binding to cell surface proteins in a natural manner. In addition, antibodies with 
conformational specificity could also be identified by using subtractive cell panning 
strategy in which target cells are selected by phage library with previous subtraction on 
equivalent non-target cells. 
 
1.5.4 Custom diagnostics and targeted therapy  
Over the years, cellular labeling, cell tracking, and diagnostic imaging are hot 
areas of biomedical research. Utilizing designed nanoparticles to facilitate biological or 
medical research, termed bionanotechnology is a scientific breakthrough that has 
tremendously influenced and continues to influence current research. The applications 
include building nanoparticles for cellular labeling and imaging, and engineering 
nanodevices or nanostructures with biological or therapeutic function. These novel 
applications would make early disease diagnose and cell tracking become possible. 
Various types of nanoparticles can be exploited and modified for this purpose, such as 
quantum dots, liposomes, certain inorganic particles, etc.  
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In human diseases, protein expression often exhibits subject specificity which 
means that individual patients have different protein profiles even they have the same 
disease. This summons the need of identifying specific disease markers or targeting 
motif for personalized treatment. Phage display technique is widespreadly used for this 
purpose since it can provide polypeptide libraries as a source of targeting ligands and 
enable the rapid identification of target-specific binders. The inclusion of targeting 
peptides would improve the cell uptake of imaging or tracking particles [114, 115]. The 
general method to improve the targeting ability of nanoparticles is to involve targeting 
agents such as antibodies and specific peptides in which phage display can play a role 
[115-117].  
The target specificity is also imperative for drug delivery. Many drugs tend to 
distribute to the whole human body through the bloodstream instead of heading into 
desired target organs or areas. In result, the curative effects of many drugs are decreased 
due to the degradation of drug by other parts of body before it reaches the desired target 
tissue. The distribution or digestion of drugs by other parts of body may also cause 
severe side effects or cytotoxicity. Moreover, the existence of physiological barriers of 
some organs also restricts the drug delivery to certain areas, for example, the human 
brain. Therefore, it is believed that the drugs conjugating with targeting ligands would 
be more effective and less toxic than normal drugs. Widespread researches are being 
conducted to build smart drug delivery systems that can deploy medication specifically 
to the target and/or release sustainably. There is also popular belief that nanoparticles or 
nanosystems would have several advantages for drug delivery: (1) nanoparticles can be 
modified to be targetable to increase therapeutic effects and reduce potential side effects 
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of drugs; (2) nanoparticles can be fabricated to protect drugs inside from possible 
digestion by stomach or livers; (3) nanoparticles could be sustainable to continuously 
release drugs. There are various types of nanoparticles used as drug carriers, such as 
biodegradable nanoparticles, polymeric micelles, liposomes, dendrimers, etc. 
This identification of targeting motifs may support the investigation of targeted 
therapies and personalized diagnostic or imaging.  
  
  26 
 
Chapter 2: Oriented Nucleation of Hydroxylapatite Crystals on 
Self-assembled Bacteriophage Bundles 
2.1 Introduction 
This work has been published as reference [118, 119]. In recent decades, 
biomimetism/bioinspiration has been a promising direction for the innovative design of 
biological materials and systems. The fabrication of novel biomaterials for bone 
regeneration by mimicking the composition of natural bones is a hot area in the 
bioengineering field. Natural bone is a hierarchically structured composite material 
assembled under organism’s fine control. It is mainly composed of organic collagen 
fibrils, non-collagenous proteins and inorganic carbonated hydroxylapatite (HAP). 
Collagen molecules self-assemble into triple helical polypeptides and then further 
assemble into fibrils which facilitate the nucleation and oriented growth of HAP crystals 
on them. Within these fibrils, non-collagenous proteins play a role in the preferential 
growth of oriented HAPs with c-axis parallel to the collagen fibrils, although other 
studies also show that the negatively charged noncollagenous proteins may simply 
inhibit extrafibrillar mineralization and the organization of the mineral inside the fibrils 
is controlled by collagen molecules [120]. Mimicking the natural method of HAP 
biomineralization on collagen fibrils is not only the key to but also a challenge for bone 
regeneration by biomimicry. To achieve this, several materials such as collagen,[121-
123] polymers, and spider silks have been employed to  demonstrate different levels of 
control over mineralization and the resultant mineralized structures showed good 
mechanical support and/or biocompatibility as the artificial bone materials.  
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M13 phage is a type of virus that specifically infects bacteria. It is a flexible 
biopolymer fiber with ~7 nm in width and ~1 µm in length which resembles the 
morphology of collagen fibrils. It has a single stranded genome DNA packed into an 
outer protein coat composed of 2700 copies of helically aligned major coat proteins 
(pVIII) on the side walls and 5 copies of various minor coat proteins (including pIII, 
pVI, pVII, and pIX) at the two distal tips. The N-terminal end of the coat protein is 
exposed to the external environment and can be genetically engineered to display 
foreign peptides on the phage surface, termed as phage display technique (Figure 2-1). 
Its main application is to study protein-protein interaction since invented in 1985. 
However, more importantly, M13 phage has also become a good candidate of 
biomaterials since it would not induce obvious toxicity and immune response in human 
beings as reported in previous literatures. This human friendly property indicates the 
safety of applying phage-inorganic composites into human bodies. 
Earlier we have found that electrostatic interaction between the Ca2+ ions and 
phage with a negatively charged surface (e.g., M13 phage genetically displaying a 
negatively charged E8 peptide sequence on the side wall or fd phage with more 
negatively charged amino acids on the side wall) can drive the assembly of the 
filamentous phages into bundles.[124, 125] In this work, we report our recent findings 
that when two peptides, which can form beta-structure and promote HAP nucleation 
and growth in their free forms, can still form beta-structures once genetically fused to 
the major coat protein on the side wall of M13 phage, which can further drive the self-
assembly of the phage into bundles and favor the nucleation and growth of HAP within 
the bundles. The N-terminus of pVIII in the filamentous phages, which consists of the 
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outer surface of filamentous phages, is negatively charged to some degree. But our 
previous results showed that the negative charge in the outer surface of wild-type M13 
phage is not sufficient to induce phage self-assembly by interacting with calcium ions. 
[124, 125] On the other hand, the driving force of phage self-assembly and mineral 
nucleation in this work is the formation of beta sheet structure instead of electrostatic 
interaction which is easily affected by environments, such as pH value and solvents. 
This work is the first attempt to employ beta sheet structure for achieving phage self-
assembly. The beta sheet structure formed in this work can easily form in water, and no 
additional inducting agent (e.g. Ca2+ ions) is needed. This finding may introduce a novel 
way for molecular self-assembly and it is an improvement of our previous works.   
The beta-structure-forming and HAP-nucleating peptides to be displayed on 
M13 phages are derived from a reported HAP-nucleating domain of dentin matrix 
protein 1 (DMP-1), one of the non-collagenous proteins that can promote HAP 
nucleation. [126] DMP-1 can be found in mineralized matrix of bone and dentin.[127] It 
is an acidic protein and processed into a 57kDa C-terminal domain and a 37kDa N-
terminal domain. The C-terminus contains both HAP-nucleating domains and collagen-
binding domains.[126] Two HAP-nucleating sites 386ESQES390 (named pE) and 
415QESQSEQDS422 (named pQ) have been identified from the C-terminal fragment of 
DMP1.[126] In the presence of calcium ions, these two HAP-nucleating domains can 
form an intermolecular beta-sheet structure in their free forms and further self-assemble 
into a microfibril endowing its ability to precisely control the nucleation of HAP 
crystals.[126] By utilizing the phage display technique, these two HAP-nucleating 
peptides from DMP-1 (pE and pQ) were separately fused into the N terminal of pVIII 
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coat protein of M13 phage so that these two peptides were displayed on the surface of 
M13 phages. The engineered phage displaying pE peptide (ESQES) was termed as E 
phage and the one displaying pQ peptide (QESQSEQDS) was termed as Q phage. With 
the help of displayed HAP-nucleating peptides, E and Q phages are expected to have 
the ability to nucleate HAP crystals on them. In addition, due to the helically chiral 
surface of bacteriophage with periodically and precisely aligned HAP-nucleating 
peptides, the nucleation sitess are expected to be orderly aligned on the bacteriophage 
surface. This fine control allows us to organize HAP crystals along phage bundles with 
a preferred orientation.  
Our strategy is to create a phage-HAP composite for mimicking the basic 
structure of natural bone. The methodology includes three main steps: first, two beta-
structure-forming and HAP-nucleating peptides derived from DMP-1 are genetically 
displayed onto the surface of M13 phages separately; the intermolecular beta-structure 
formation between the peptides displayed on the neighbouring phages drives the self-
assembly of phages into bundles to simulate collagen fibrils in nature bone; finally, 
HAP crystals are precisely nucleated from HAP supersaturated solution onto the HAP-
nucleating beta structures on the formed engineered phage bundles with c-axis preferred 
orientation. 
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Figure 2-1  Phage display technique. a) TEM images of wild type M13 phages. b) 
Display of a foreign peptide on the side wall of M13 phage by fusing the peptide to 
the N-terminus of pVIII. c) 3D model of M13 phage pVIII protein coat (PDB id: 
1ifd). 
 
2.2 Materials and Methods 
2.2.1 Reagents.  
Luria broth (LB) medium, tetracycline, chloramphenicol, and polyethylene 
glycol (PEG) were purchased from Sigma Co. Tris was obtained from Fisher. 
Kanamycin was obtained from Fluka and sodium chloride was purchased from EMD. 
2.2.2 Molecular cloning of M13 bacteriophage PVIII display.  
Phage display technique was used to introduce two DMP-1 derived peptides (pE: 
386ESQES390 and pQ: 415QESQSEQDS422) into the N-terminus of M13 phages’ major 
coat protein (PVIII) respectively. Three primers were designed and synthesized by 
Invitrogen to introduce the desired peptides.  
pE primer:  
5’-ATCCATGGCGGAATCTCAGGAATCTGATCCCG CAAAAGC-3’;  
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Reverse primers: 5’-GCAAGCTTTTATCAGCTTGCTTTCGAG-3’.  
Then M13KO7 phage replicative form (RF) DNA was used as template with pE 
or pQ primer and reverse primer to do PCR amplification. The purified PCR product 
was digested with appropriate restriction endonucleases (NcoI and HindIII) and fused 
into linearlized phagemid. The recombinant phagemids were confirmed by DNA 
sequencing (McLab Inc., CA).  
2.2.3 The production, amplification, and purification of engineered phage.  
The recombinant phage virions (engineered phage) displaying two DMP-1 
derived peptides were obtained by incubating one tube (5 ml) of recombinant 
phagemids-transfected Escherichia coli TG-1 strain with helper phage, wild type 
M13KO7 virions, for one hour at 37°C. LB-agar plates, antibiotics, LB broth, and 
chloramphenicol antibiotics were used during this process. The 5 ml recombinant phage 
virions were then transferred to 1L LB medium containing chloramphenicol on a 
shaking incubator at 37°C. Kanamycin and IPTG were added to make final 
concentration of 70 µg/ml and 0.1 mM, respectively. After obtaining enough engineered 
phage, we did PEG double precipitation to purify it. The overnight culture was first 
centrifuged at 3000g for 15 min at 4°C with a Beckman Coulter high-performance 
centrifuge. The supernatant was collected and recentrifuged at 8200g for 15min at 4oC. 
The precipitate was suspended by 0.15 volume of 20% PEG/2.5M NaCl solution and 
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stored at refrigerator overnight. Phage precipitate was collected at 8200g for 1 hour at 
4oC, dissolved in Tris-Buffered Saline (TBS), and recentrifuged for 10 min to clear. The 
final phage precipitate was diluted by appropriate volume of double distilled water. The 
concentrations of both harvested engineered phages were determined via ultraviolet-
visible absorption at 269 nm and the suspensions were diluted by ddH2O to have the 
same value of optical density (OD269nm=1). 
2.2.4 The preparation of HAP supersaturated solution.  
Supersaturated HAP solution was prepared from HAP powder (Sigma) as 
described in our previous publications.[124, 125] Briefly, a stock solution was prepared 
first by dissolving HAP powder (Sigma) with 100mM of hydrochloric acid to reach a 
concentration of 50 mM of calcium. Then the HAP stock solution was diluted by 
sodium chloride solution to achieve the final concentration of 200 mM sodium chloride 
and 4 mM of calcium. The pH value was carefully adjusted to 7.01 with 0.05 M 
potassium hydroxide. 
2.2.5 Nucleation of phages in HAP supersaturated solution.  
20 µl of 0.2 mg/ml phage suspension was mixed with 1ml supersaturated HAP 
solution in vials. After 5, 10, 15, and 20 days, 10 ml solution was transferred onto a 
transmission electron microscopy (TEM) copper grid, rinsed to remove soluble salts and 
characterized by TEM.  
2.2.6 Ultraviolet (UV) Absorption and Circular Dichroism (CD) spectroscopy.  
300 µl of engineered phages fused with pE or pQ, were measured under UV and 
CD. Mixed phages were made by mixing 150 µl E phages and 150 µl Q phages. UV 
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absorption spectra were measured using a spectrophotometer. CD spectra were obtained 
using a JASCO 750 circular dichrometer. CD spectra were measured using a spectral 
band width of 1 nm in 0.1 cm cells. Measured CD spectra of the phages were then 
smoothed and plotted as [θ] in units of deg10-3cm2 dmol-1. Each spectrum was the 
average of five measurements. The phage concentration used for the analyzed CD 
measurements is 0.2 mg ml-1. Concentrations of phage solutions were determined from 
absorbance measurements and published extinction coefficients in unit of mg-1cm2 of 
3.84 at 269 nm for M13 phages.[128] 
2.2.7 Transmission Electron Microscopy Characterization.  
The TEM images were obtained using a transmission electron microscope 
(JEOL2000, 200 kV). For pure phage samples, 10 µl of phage solutions was dried on 
the copper grids and washed by 10 µl ddH2O. Then the samples were negatively stained 
by 1% uranyl acetate (UA). For nucleation samples, 10 µl mineralized phage solution 
from each nucleation test was put onto the copper grid and allowed to dry. Then the 
sample was washed by distilled water twice to remove any soluble salts. Since no 
staining was done on the nucleation samples, under TEM the filamentous structures 
could be seen only when the phage and minerals were associated together. 
2.3 Results and Discussions 
 Both pE and pQ peptides were derived from DMP1 and could direct the 
deposition of HAP crystals by an intermolecular beta-sheet structure between them.[126] 
In order to test whether these two peptides displayed on separate phages still function as 
their free form in DMP1, purified E and Q phages were mixed together and incubated 
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for 1 day (For convenience, we termed mixed E and Q phages as EQ phages.). At the 
same time, E phages and Q phages were separately incubated for 1 day as control.  
Only individual flexible phage fibers were observed in pure E phage sample 
(Figure 2-2a), indicating no interactions occurred between E phages. For Q phages, 
much to our surprise, they could form small bundles in water by themselves (Figure 
2-2b). The bundles were flexible and randomly distributed, each of which was 
composed of 3-4 individual Q phages along the width direction. This fact suggests the 
presence of certain driving force that facilitates the assembly of Q phages into bundles. 
When mixed together, E and Q phages could self-assemble into larger bundles in which 
individual phages were arranged parallel in a side-by-side fashion (Figure 2-2c). These 
bundles were relatively rigid and longer than Q bundles. About 9-10 phages comprised 
one bundle of EQ phages along the width direction. These results show that E and Q 
phages are able to self-assemble into bundles under a stronger driving force compared 
with the formation of the Q phage bundles.  
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Figure 2-2. TEM images of engineered phages. a) E phages; b) Q phage bundles; c) 
mixed EQ phage bundles. d) Circular dichroism spectra of wildtype, E, Q and EQ 
phages. 
 
Since pE and pQ are capable of forming intermolecular beta-sheet structures in 
DMP-1,[126] we expect that engineered E and Q phage bundle should also form beta-
sheet structures. In order to demonstrate the secondary structure, circular dichroism (CD) 
measurements were performed on engineered phages while wild-type phage served as 
control. The CD spectrum of wild-type phages confirmed that α-helix existed as the 
major protein secondary structure of intact M13 phage (Figure 2-2d). Its spectrum had 
one positive band at 192 nm and two negative bands at 208 nm and 222 nm, 
corresponding to the parallel πàπ*, perpendicular πàπ*, and well-known nàπ* 
transitions of α-helix, respectively.[129] It has been well documented that α-helix is the 
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major structure of pVIII coat protein and each phage has ~3000 copies of pVIII protein, 
so the presence of α-helix in the spectrum is anticipated. Using the method from 
Whitmore,[130] the α-helical and β-sheet contents of wild type phage were estimated to 
be 74% and 1%, respectively. The CD spectrum of E phages (Figure 2-2d) shows a 
combination of α-helical and β-sheet structures, which were estimated to be 63% and 
16%, respectively. Since no obvious interactions between individual E phages could be 
observed from the TEM, we believed that the increased β-sheet contents of E phages 
were due to the hydrogen bonding between displayed pE peptides and neighboring 
pVIII protein on the surface of an individual phage. Q phages have a similar CD 
spectrum demonstrating a combination of α-helix and β-sheet structures, but its β-sheet 
contents were higher (22%) than those in wild type and E phages. In our opinion, the 
driving force of Q phage bundles is possibly the hydrogen bonding in β-sheet structure 
formed between displayed pQ peptides on neighboring Q phages. The CD spectrum of 
mixed E and Q phages (Figure 1d) shows a highest content of β-sheet (29%) and lowest 
content of α-helix (43%) among all samples. Considering the large bundles formed 
between E and Q phages (Figure 2-2c), we conclude that the potential driven force was 
the hydrogen bonding in β-sheet structure formed between pE and pQ peptides 
displayed on pE and pQ phages, respectively. In addition, increased β-sheet structures 
were formed between E and Q phages than between Q phages only. These results are 
consistent with the earlier finding that pE and pQ from DMP1 can form an 
intermolecular beta-sheet structure.[126] 
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Figure 2-3  TEM images of nucleation of HAP on E and Q phages after incubation 
in supersaturated HAP solution for 10 days and 20 days. a) HAP nucleation on E 
phages for 10 days. b) HAP nucleation on E phages for 20 days. c) HAP nucleation 
on Q phages for 10 days. d) HAP nucleation on Q phages for 20 days. 
 
Subsequently, we did a series of in vitro HAP nucleation tests on E and Q 
phages. Specifically, 20 µl of E and Q phages were separately incubated in 1 ml 
supersaturated HAP (pH=7.01) solution[131] at room temperature. Mineral deposited 
samples were rinsed and characterized under TEM without any staining after 5 days as 
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interval. On E phages, only some amorphous calcium phosphate phase could be 
observed after incubation for 10 days (Figure 2-3a). But on day 20, almost all E phage 
fibers were coated by amorphous calcium phosphate, resulting in a necklace structure 
(Figure 2-3b). The amorphous phase of nucleated minerals was confirmed by the 
electron diffraction (ED) pattern (Figure 2-3b). While on Q phage bundles, small 
minerals could be found after incubation for 10 days (Figure 2-3c). The diffraction spots 
from the (211) and (203) planes of HAP in ED pattern of Q phage samples indicated 
that the minerals were HAP poly-crystals. At 20 days, those HAP crystals had grown 
into larger crystals but no preferred orientation was observed from the ED pattern 
(Figure 2-3d). In addition, Figure 2-3c and Figure 2-3d suggest that the nucleation sites 
on Q phage bundles were not distributed uniformly. Similarly, we mixed 10 µl of E 
phages and 10 µl of Q phages with equal concentrations into 1 ml of HAP 
supersaturated solution. On day 5 and 10, small HAP crystals appeared on EQ phage 
bundles. The crystalline structures were verified by the ED patterns. But no obvious 
preferred orientations of the crystals were found (Figure 2-4a and b). On day 15 and 20, 
more and larger HAP crystals appeared along EQ phage bundles (Figure 2-4c and d). 
The ED patterns of the bundles show arcs corresponding to (00l) planes of HAP, 
indicating that HAP crystals on bundles are oriented with their c-axis preferentially 
parallel to the phage bundles.[125] These results show that E and Q phages could co-
self-assemble to induce oriented HAP nucleation while individual E phages or Q phages 
by themselves could not.  
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Figure 2-4  TEM images of the HAP nucleation on EQ phage bundles after 
incubation for: a) 5 days, b) 10 days, c) 15 days and d) 20 days. 
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The mechanism of bone biomineralization has been controversial. [120, 132-134] 
Most recently, a new mechanism was proposed,[135] where an amorphous calcium 
phosphate phase forms “liquid-droplets” that can interact with the non-collagenous 
proteins and then bind to the preformed collagen matrix. However, we did not find the 
evidence of converting amorphous calcium phosphate phase into crystalline one in our 
study. We believe that the orientation control of nucleated HAP crystals on EQ phage 
bundles was directed by the β-sheets formed between E and Q phages (Figure 2-5). It is 
known that pE and pQ could self-assemble into microfibrils by forming intermolecular 
β-sheets.[126] When displayed on phage, pE and pQ peptides are fully exposed and free 
to interact with other molecules. Therefore, when E and Q phages were mixed, 
displayed pE and pQ could form β-sheets between neighboring phages which induced 
the formation of EQ phage bundles (Figure 2-2a). This was also confirmed by the 
relatively high content of β-sheet in the CD spectrum of EQ phage bundles (Figure 
2-2d). The possible β-sheet formed was simulated in Figure 4b. Aspartic acid (Asp, D) 
is the following amino acid of inserted foreign peptides in pVIII proteins of M13 phages. 
We believe that it is also important for inducing HAP crystals so that it was included in 
our models. Previous studies found that negatively charged amino acids (D, E or 
phospho S) had the trend to induce the nucleation of HAP crystals.[136, 137] From 
Figure 2-5b, we can see that E4, D6 from E1S2Q3E4S5D6 and D1, D3, E5, E9 from 
D1S2D3Q4E5S6Q7S8E9Q10 are on the same side of β-sheet which could create an 
attracting center for calcium ions and thus initiate the nucleation of HAP crystal. 
In our experiments, HAP crystals nucleated on EQ bundles were oriented with 
their c-axis preferentially parallel to the phage bundles (Figure 2-4c and d). Previous 
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work has demonstrated that β-sheets formed from pE and pQ could nucleate HAP 
crystals on them. [126] We further made a model to illustrate how the β-sheets within 
phage bundles facilitated the oriented nucleation and growth of HAP crystals. Figure 
2-5c, d, and e demonstrate glutamic acids and aspartic acids from both pE and pQ can 
attract calcium ions and trigger the nucleation process. Specifically, E4 and D6 from pE 
as well as E5 and E9 from pQ are able to attract 4 calcium ions and those attracted 4 
calcium ions on the β-sheet can perfectly match 4 calcium ions in the (001) plane of 
HAP crystals (Figure 2-5c and d). As we know, mostly, HAP crystal tends to grow 
along its [001] direction. Therefore, the electrostatic interaction and stereochemical 
match will further encourage the nucleation of HAP crystals on the β-sheet with their c-
axis parallel to the phage bundles. The nucleated HAP will grow along its c-axis, that is, 
perpendicular to the plane where the nucleating β-sheet is lying in between neighboring 
phages. Since the long axis of phage is also perpendicular with the β-sheet, the c-axis of 
HAP crystals should be parallel to phage bundles (Figure 2-5f). This structure greatly 
mimicked the lowest level of hierarchical structure of natural bone in which HAP 
crystal are nucleated and grown with their c-axis preferentially parallel to the collagen 
fibrils.[136]  
Our results supported the previous findings that pE and pQ can form β-sheet and 
nucleate HAP crystals. [126] Moreover, this work suggests the feasibility in the field of 
bone regeneration of using genetically modifiable biomaterials (e.g. bacteriophage) 
displaying pE and pQ and inducing HAP deposits by forming β-sheets. Scientists are 
always looking for a new method to achieve self-assembly. In this study we 
demonstrate the feasibility by taking advantage of forming β-sheet intermolecular 
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bridge without any artificial inductive or additive reagents. β-sheet structure is a 
common type of secondary structures of peptides or protein formed via hydrogen 
bonding. It is a spontaneous and naturally evolved process. If fused on specific 
positions of genetically engineerable biomaterials, pE and pQ are able to act like leucine 
zipper peptides[138] to assemble biomaterials into hierarchical structures with a precise 
control by forming β-sheets. We previously found that Ca2+ ions could induce the 
bundling of negatively charged phages.[124, 125] However, the mineralization of such 
electrostatically bound bundles is faster than that of beta-structure-stabilized bundles 
although both bundles induce the formation of oriented HAP along the bundles. This 
fact may reflect the different mechanisms involved in the mineralization in this work 
and suggest that beta-structure driven nucleation may be slower. 
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Figure 2-5 The three dimensional simulation of possible HAP nucleation 
mechanism. a) 3D model of possible EQ phage bundles. b) The simulation of 
intermolecular beta sheet formed by two HAP nucleating peptides displayed on 
phage pVIII. This model includes the aspartic acid (D) which is the following 
amino acid right after the inserted foreign peptides in pVIII due to its possible 
contribution to the beta sheet formation. c) describes the possible mechanism of 
the HAP nucleation and growth along c-axis due to the specific match between the 
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negatively charged amino acid in HAP nucleating peptides forming intermolecular 
beta sheet and the (001) plane of HAP crystals. d) shows the four calcium ions on 
HAP (001) plane that can perfectly match four negatively charged amino acids. e) 
is a closer look of electrostatic attraction between matched negatively charged 
amino acids and calcium ions. f) is the 3D model which schematically illustrates the 
possible mechanism of HAP crystal nucleation and oriented growth triggered by 
EQ phage bundles.   
 
2.4 Conclusions 
In summary, we have used M13 bacteriophage with pE and pQ derived from 
DMP1 protein genetically displayed on the surface to form self-assembled bundles with 
c-axis oriented HAP crystals decorated along the bundles. Displayed pE and pQ formed 
a β-sheet structure, inducing the self-assembly of E and Q phages into EQ phage 
bundles. This formation of β-sheet can be applied as a general method to induce precise 
assemblies between engineerable biomaterials. We also found HAP crystals could be 
nucleated on EQ bundles with their c-axis preferentially parallel to the phage bundles. 
This structure greatly mimicked the lowest level of hierarchical structure of natural 
bone in which HAP crystal are nucleated and grown with their c-axis preferentially 
parallel to the collagen fibrils. The oriented nucleation and growth arose from the fact 
that glutamic acids and aspartic acids from pE and pQ attracted calcium ions with a 
pattern matching with calcium ions in the (001) plane of HAP crystals. Such specific 
match further induced the nucleation of HAP crystals on the β-sheet and directed the 
nucleated HAP crystal to grow along their c axis. Our work demonstrated a new route 
for fabricating bone repair materials through biomimicking and bioinspiration.  
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Chapter 3: Bacteriophage-Gold Nanocomposites As a Model to 
Study Transmission Electron Microscopy of bioinorganic 
nanohybrids 
3.1 INTRODUCTION  
This work has been published as reference [139]. In recent years, bioinorganic 
nanohybrids composed of biological macromolecules and functional inorganic 
nanomaterials have revealed many unique properties that show promise for the future. 
Transmission electron microscopy (TEM) is a popular and relatively simple tool that 
can offer a direct visualization of the nanomaterials with high resolutions. When TEM 
is applied to visualize bioinorganic nanohybrids, a treatment of negative staining is 
necessary due to the pres- ence of biological molecules in the nanohybrids except for 
those with densely packed inorganic materials. However, the conventional negative-
staining procedure for regular biological samples cannot be directly applied to such 
bioinorganic nanohybrids. To image a specific bioinorganic nano- hybrid, negative-
staining factors such as negative stain type, working pH, staining time, and dry- ing 
method, should be identified. Currently, no detailed studies have been done to 
investigate how to adjust negative-staining factors based on specific bioinorganic 
nanohybrids. In this study, bacte- riophage-gold nanoparticle hybrids were chosen as a 
model to systematically study the effects of each factor on the negative staining of the 
nanohybrids. The best staining conditions for gold nano- particle-phage nanohybrids 
were obtained and the effects of each factor on the negative staining of general 
nanohybrids were discussed. This work indicates that with proper staining it is possible 
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to use TEM to visualize directly both biological and inorganic components without 
introducing any artifact.  
Nano-scale inorganic materials exhibit unique properties and show great 
promise for the future [140-143]. One particular challenge with nano-scale inorganic 
materials has been in assembling them into well-defined structures or integrating them 
into large-scale devices. One strategy incorporates the use of self-ordered biomolecules, 
which are directly obtained from Nature such as nucleic acids, proteins and viruses, to 
organize nanomaterials into pre-designed patterns. The combination of these biological 
molecules with functional inorganic nano-materials have led to many hierarchical 
nanostructure organizations with controlled shape, size, alignment and orientation [111, 
144-148]. The characterization of the designed bio-inorganic nano-hybrids is a crucial 
step in the development of novel nanomaterials. A variety of imaging techniques have 
been applied in this field such as transmission electron microscopy (TEM), atomic force 
microscopy (AFM), scanning electron microscopy (SEM) and fluorescence microscopy. 
Among them, TEM is a relatively simple technique that can offer a direct visualization 
of the individual nano-hybrids with high resolutions. Therefore, it has become one of 
the most commonly used techniques for the characterization of nanomaterials.  
It is easy to visualize inorganic nanomaterials such as gold nanoparticles under 
TEM without any staining due to the high contrast between the inorganic materials and 
the underlying supporting film such as carbon. Biological molecules are mainly 
composed of carbon, hydrogen, and nitrogen atoms, and thus are only recognized under 
TEM with heavy metal ion staining. Bio-inorganic nano-hybrids are composites of 
biological molecules with functional inorganic nanomaterials. If biological molecules 
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are densely packed by inorganic materials, the structures of the hybrids can be observed 
without staining. Our previous results have shown that in a nano-composite of silica-
coated bacterial flagella, both silica and flagella could be recognized without staining 
[149]. However, if inorganic materials are loosely arranged around biological molecules, 
only inorganic materials having higher molecular weights can be visualized. In such 
characterization, direct evidence showing the close proximity between inorganic and 
biological components, which can help us understand the interactions between both 
components, is missing. Therefore, negative staining is needed to visualize the 
biological components in such nano-hybrids so that both components can be observed 
under TEM.  
Negative staining is based on the principle that heavy staining ions are repelled 
by the charged groups of the specimen and sit along biological molecules [150]. 
However, the conventional negative-staining procedure for regular biological samples 
cannot be directly applied to such bio-inorganic nanohybrids. For a specific bio-
inorganic nanohybrid, some negative-staining factors should be modified, such as the 
type of negative stain, working pH, staining time, and drying method. In this work, 
bacteriophage-gold nanoparticle nanohybrid was used as a model to systematically 
study the effects of each factor on the negative staining of the nanohybrids (Figure 3-1 
b). The optimum negative-staining condition for bacteriophage-gold nanoparticle hybrid 
was obtained and the effects of each factor on the negative staining of the nanohybrids 
are discussed.  
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Figure 3-1  a) M13 wild type phage particles composed of ~2700 copies of major 
coat proteins (pVIII) and 5 copies of each minor coat protein (including pIII, pVI, 
pVII, and pIX); b) Positively charged Au-NPs interacted with anionic phage 
particles into bundle structures.  
 
3.2 Materials and Methods 
3.2.1 Materials 
Uranyl acetate (UA) powder was purchased from Ted Pella Inc. 
Phosphotungstic acid (PTA) was purchased from Ted Pella Inc. Trehalose was 
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purchased from Sigma Inc. Gold chloride solution was purchased from Sigma Inc. 
Polyethylenimine (branched, average MW=~25000) was purchased from Sigma Inc. 
Sodium borohydride powder was purchased from Sigma Inc. TEM grids were 
purchased from Ted Pella Inc. M13 wild type bacteriophage was purchased from New 
England Biolabs Inc.  
3.2.2 M13 Amplification 
200 µL overnight ER2738 E.coli culture and 1 µL phage suspension were added 
into a 20 mL LB culture in a 250 ml flask. The flask was incubated at 37 °C with 
shaking for 4-5 h. After incubation, the culture was centrifuged at 4500 g for 20 min to 
remove E. coli cells. Then the top 16 mL of the supernatant was transferred into a new 
tube and 4 mL of 2.5 M NaCl/20% PEG-8000(w/v) was added to precipitate the phage. 
After 4 hours of precipitation at 4 °C, the phage was pelleted by centrifugation at 12000 
g for 15 min. Supernatant was discarded and the phage pellet was re-suspended in 1 mL 
TBS buffer. 200 µL 2.5 M NaCl/20% PEG-8000 was added into the re-suspended 
phage solution and the mixed solution was allowed to incubate on ice for 1 h. The 
phage was pelleted again by centrifugation at 14000 g for 10 min. Supernatant was 
discarded and the phage pellet was re-suspended in 200 µL TBS buffer. The 
quantification of phage was achieved by monitoring its OD269nm. Concentrations of 
phage solutions were determined from absorbance measurements and using published 
extinction coefficients in unit of mg-1cm2 of 3.84 at 269 nm for M13 phages [128]. 
Roughly, an OD269nm of 1 means the concentration of the phage in solution is about 
1×1013 pfu/mL .  
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3.2.3 Synthesis of Gold Nanoparticles 
AuNPs were synthesized by using a reported method  [151]. Specifically, 15 µL 
5% (w/w) polyethylenimine (PEI) (branched, average MW=~25000) was added into 1 
mL 0.2% gold chloride (HAuCl4) solution with stirring. The color of the solution 
changed from yellow to orange. Then 20 µL of 5M NaBH4 solution was added into the 
PEI/HAuCl4 solution with violent stirring. Immediately, the solution color turned from 
orange to dark red, the color of nano-sized gold particles.  
3.2.4 Preparation of Phage-Gold Nanoparticle Hybrid 
100 µL phage solution (1.5×1013 pfu/ml) was added into 1 mL gold nanoparticle 
solution and mixed well. The mixture was incubated at room temperature for 4 hours. 
Gold-phage hybrids were formed and slowly precipitated to the bottom of the tube. 
Hybrids were pelleted by centrifugation at 10000 g for 1 min and re-suspended in 1 mL 
water. 
3.2.5 Negative Staining 
In a typical UA staining, 10 µL Au-NPs-phage hybrid solution was applied onto 
a formvar-coated TEM grid for 3 min During this process, the Au-NPs-phage 
nanohybrids was absorbed to the supporting film. The rest of the solution was wicked 
from the edge of the grid by the wedge of the filter paper. Immediately, 10 µL 0.5% UA 
solution (pH=4.5) was applied to the specimen for 10 s. Then, the stain solution was 
wicked from the edge of the grid by the wedge of the filter paper. Lastly, the TEM grid 
was dried by a hair drier and characterized under TEM (Zeiss 10). In this way the 
effects of each factor on the negative staining of the nanohybrids could be analyzed. 
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3.2.6 Pre-fixation with 1% Glutaraldehyde (GA) 
10 µL Au-NPs-phage solution was applied onto a formvar-coated TEM grid for 
3 min while the specimen was absorbed to the supporting film. The rest of the solution 
was wicked from the edge of the grid by the wedge of the filter paper. 20 µL 1% GA 
solution was applied onto the specimen for 20 min. After the incubation, the GA 
solution was wicked from the edge of the grid by the wedge of the filter paper and the 
specimen was washed 3 times by water. Then 10 µL 0.5% UA solution (pH=4.5) was 
applied on the specimen for 10 s. Then, the stain solution was wicked from the edge of 
the grid by the wedge of the filter paper. Lastly, the TEM grid was dried by a hair drier 
and characterized under TEM (Zeiss 10). 
3.3 Results 
3.3.1 Preparation of Gold Nanoparticles. 
 HAuCl4 was reduced by NaBH4 into gold nanoparticles (Au-NPs) and stabilized 
by polyethylenimine (PEI) molecules. After the reaction, the Au-NP solution became 
transparent and its color turned to dark red. Then the solution was diluted and 
characterized under a TEM. Over large areas, only well-dispersed nanoparticles could 
be observed with a uniform size of ~5-7 nm (Figure 3-2a). In addition, a typical electron 
diffraction pattern corresponding to gold crystals was found from the nanoparticles, 
suggesting the nanoparticles in the image are gold crystals. Since the Au-NPs were 
stabilized by highly-branched PEI molecules, the synthesized Au-NPs should be 
positively-charged due to the presence of the amino groups from the surrounding PEI 
molecules. 
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3.3.2 Wild-Type M13 Bacteriophage. 
Wild-type M13 phage is a flexible nanofiber with its single stranded DNA 
(ssDNA) genome packed into a protein coat which is composed of 2700 copies of major 
coat proteins (pVIII) and 5 copies of each minor coat protein (including pIII, pVI, pVII, 
and pIX) [10]. 2700 copies of pVIII proteins form its side wall while 5 copies of pIII 
and pVI are located at one tip and 5 copies of pIX and pVII at the other tip (Figure 3-1 
a). The ssDNA genome encodes a total of 11 proteins including 5 structural coat 
proteins. From its surface chemistry, the amino terminus of each pVIII protein is 
exposed to the surface with the first five residues (AEGDD) extending away from the 
phage. So it can be easily figured out that on the phage surface there are 2700 copies of 
Glu and 5400 copies of Asp both of which have carboxyl groups, leading to a 
negatively charged surface. The experimental isoelectric point (pI) value of 4.2 also 
confirmed the negative phage surface charge [152]. With a high concentration, phage 
particles tend to form bundle structures if polycationic molecules are added [125]. It 
was believed that the addition of polycationic molecules can trigger the assembly of 
neighboring phage particles via electrostatic interactions. In this work, the wild type 
M13 phages after the amplification were quantified by monitoring its OD269nm. Roughly, 
1 OD269nm means the concentration of the phage in solution is about 1×1013 pfu/mL. The 
detailed calculation could be found in supporting information. The phage was stocked 
and used at a concentration of 1.5×1013 pfu/mL (OD269nm=1.5). Usually, up to 1×1014 
phages could be harvested from 1 liter of LB culture. In order to know the morphology 
of the wild type M13 phage, the viruses were stained with 0.5% UA and observed under 
a TEM (Figure 3-2b). Every single M13 phage particle has a flexible rod-like shape 
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with a diameter of ~6.5 nm and a length of ~930 nm (Figure 3-2b), which is consistent 
with previous literatures [10].  
3.3.3 Gold Nanoparticle-Phage Hybrids. 
After a phage solution was injected into the Au-NP solution, immediately, Au-NP-
phage hybrids were formed and slowly precipitated to the bottom of the tube. Free Au-
NPs were then removed by centrifugation and the hybrids were re-suspended in water. 
Again, the gold-phage hybrids slowly precipitated to the bottom of the tube, leaving the 
supernatant clear and colorless (Figure 3-2c). A small quantity of the hybrids was 
characterized under TEM without staining. Most Au-NPs were aligned into large belts, 
forming a net-like structure (Figure 3-2d). Only a few free Au-NPs were observed away 
from the belts, indicating almost all of the free Au-NPs were removed during washing. 
We believe positively-charged Au-NPs electrostatically interacted with M13 phages to 
induce the formation of bundle-like Au-NP-phage hybrids. However, without any 
staining (Figure 3-2d), this hypothesis cannot be experimentally verified because we 
could not see any phage particle or any phage-Au-NP connections directly. In order to 
visualize the structural details of such hybrids, a negative staining was applied to the 
hybrid specimen.   
3.3.4 Best Negative Staining Conditions. 
In order to obtain the best staining condition to image the phage-gold 
nanohybrids, the effects of each factor on the negative staining of the nanohybrids were 
systemically studied. Specifically, 10 µL hybrid solution was applied onto a formvar-
coated TEM grid for 3 min. During this time, the specimen was absorbed to the 
supporting film. The rest of the solution was wicked from the edge of the grid by the 
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wedge of the filter paper. Immediately, 10 µL 0.5% UA solution (pH=4.5) was applied 
on the specimen for 10 s. Then, the stain solution was wicked from the edge of the grid 
by the wedge of the filter paper. Finally, the TEM grid was dried by a hair drier and 
characterized under TEM. With the help of UA, phage particles were negatively-stained 
so that both Au-NPs and phage particles could be observed under TEM (Figure 3-3a, b). 
As a result, it is clearly seen that the M13 phage particles are interacted with positively-
charged Au-NPs, which could be a direct evidence to prove our initial hypothesis.  
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Figure 3-2  a) Synthesized gold nanoparticles and the electron diffraction pattern; 
b) wild type M13 phages stained with 1% UA; c) gold-nanoparticle-phage hybrids 
precipitation; d) TEM image of the hybrid precipitation from c. 
 
One problem was in some areas the Au-NPs were covered by the heavy stain-
salts so that some of the nanoparticles were not easily recognized. This situation 
resulted from the pH of the staining solution. As previously mentioned, the isoelectric 
point of M13 phages is about 4.2 which is lower than the pH value of the staining 
solution (4.5). Hence, the staining may contain some positive-staining effects which 
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darkened the biological structures in certain areas. Decreasing the pH of the stain 
solution could solve this problem. However, a stain solution with a low pH will cause 
other problems to the nanohybrids which will be mentioned later in more detail. In fact, 
the synthesized Au-NPs have an excellent contrast and could still be recognizable in a 
light staining. Therefore, when we reduced the concentration of the stain to 0.5%, this 
problem was reduced (Figure 3-4b). We carefully highlighted the Au-NPs in the 
negatively-stained sample (Figure 3-4b) and compared it with the non-stained sample 
(Figure 3-2d). The results clearly showed that the nanohybrids were nicely stained and 
most Au-NPs were still on the hybrids after negative staining (Figure 3-3). 
 
 
Figure 3-3  Comparison of Figure 3-2d and Figure 3-4b. Au-NPs in Figure 3-4b are 
highlighted by red circles. The density of Au-NPs on the hybrids after negative 
staining is almost the same as without staining. 
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Figure 3-4 a) Au-NP-phage hybrids were stained with 0.5% UA solution (pH=4.5, 
10 s of staining, rapid drying); b) high resolution image of a); c) Au-NP-phage 
hybrids were stained with 0.5% PTA solution (pH=7, 10s of staining, rapid 
drying); d) high resolution image of c). 
 
3.3.5 Choice of Stains. 
Besides UA, phosphotungstic acid (PTA) is another popular stain for negative 
staining. Usually, the working concentration is about 0.5%-2% at a neutral pH. Here, 
we tried to use 0.5% PTA solution (pH=7.0) for the staining to check if PTA is better 
than UA for this system. Under similar condition using 10s of the staining solution and 
rapid drying, the structure of Au-NP-phage hybrid was greatly changed as a result of the 
  58 
 
staining process. Specifically, individual phage particles within bundles were detached 
from each other and there was no dense packing of the Au-NPs with phage particles 
could be found (Figure 3-4c&d). Moreover, a lot of Au-NPs were detached from phage 
bodies during the process of staining (Figure 3-4d). Such detachment could not be 
found from the non-stained specimen (Figure 3-2d). These results suggest that the 
staining ions from the PTA solution interrupted the interactions between Au-NPs and 
phage particles, resulting in the detachment of Au-NPs from phage particles. Without 
the help of positively charged Au-NPs, phage particles could not be attracted any 
further so they repelled each other and finally broke the densely packed bundle 
structures. Therefore, PTA is not a suitable stain for this nanohybrid because it 
interrupts the interactions between the two components and greatly changes the hybrid 
structures. From this PTA-stained sample only inaccurate structural details were 
obtained. 
3.3.6 Choice of the Concentrations of the Stain. 
In order to test if a higher concentration of the stain is better in this system, we 
increased the concentration of the UA solution from 0.5% up to 2% and kept other 
factors the same as in the optimal condition (10s of staining, rapid drying, pH=4.5). 
When stained with 2% UA, the Au-NP-phage hybrids were heavily darkened (Figure 
3-5a). Densely packed phage bundles were still recognizable with careful identification, 
but the Au-NPs within Au-NP-phage hybrids were totally covered by the heavy stain 
and became unrecognizable (Figure 3-5a). As previously mentioned, the isoelectric 
point of M13 phages is about 4.2 which is lower than the pH of the staining solution 
(pH=4.5). So such staining by the 2% UA solution caused an obvious positive-staining 
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effect which heavily darkened the Au-NP-phage hybrids. This test suggested that a 
lower concentration (0.5%) of UA solution brought fewer positive-staining effects to 
the specimen and worked better on the Au-NP-phage nanohybrids than a concentrated 
UA solution (2%).  
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Figure 3-5  a) Au-NP-phage hybrids were stained with 2% UA solution (pH=4.5, 
10s of staining, rapid drying); b) Au-NP-phage hybrids were stained with 0.5% UA 
solution (pH=4.5, 1 minute of staining, rapid drying); c) high resolution image of 
b); d) Au-NP-phage hybrids were stained with 0.5% UA solution (pH=3.5, 10s of 
staining, rapid drying); e) Au-NP-phage hybrids were stained with 0.5% UA 
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solution (pH=4.5, 10s of staining, slow drying); f) Au-NP-phage hybrids were pre-
fixed by 1% GA solution and stained with 0.5% UA solution (pH=3.5, 1 minute of 
staining, slow drying). 
 
3.3.7 Staining Time. 
Staining time is another factor that may affect the negative staining. We 
increased the staining time from 10 s up to 1 min and kept all other factors the same as 
the optimal condition (0.5% UA, rapid drying, pH=4.5). Again, the structure of Au-NP-
phage hybrid was greatly changed during the staining. Phage particles were separated 
from each other and most of the Au-NPs were detached from the phage bodies (Figure 
3-5b&c). These results suggest that the staining ions from the UA solution are more 
electrostatically attracted to phage particles than Au-NPs and therefore slowly replaced 
Au-NPs. This replacement needs a longer time to occur (1 min). Consequently, after a 
longer time of staining, the densely packed bundle structures were broken. Unlike the 
stain PTA, UA molecules needed a longer time to break up the Au-NP-phage hybrids. 
Therefore, we believe staining with 0.5% UA for a short time (10 s) is a better choice 
for this model system. 
3.3.8 pH of the Stain. 
The pH of the stain solution plays a crucial role in most staining processes.  It is 
known that in negative staining heavy staining ions are repelled by the charged groups 
of the specimen and sit along biological molecules whereas in positive staining  heavy 
metals react with and attach to biological molecules. The charges on the surface of the 
biological molecules are mainly dependent on its isoelectric point and local pH value. 
Since the isoelectric point is constant for a specific biological molecule, the surface 
chemistry of the molecules is dependent on the local conditions.  
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In the Au-NP-phage hybrid system, the isoelectric point of M13 phages is about 
4.2, so in theory, a lower pH of the UA solution should not cause positive staining 
effects and will have a better performance in staining. Therefore, we decreased the pH 
of the UA solution from 4.5 to 3.5 while keeping all other factors the same as the 
optimal condition (0.5% UA, rapid drying, 10s of staining). Densely packed phage 
bundles were nicely stained by the staining ions and Au-NPs could also be observed 
clearly (Figure 3-5d). However, most Au-NPs were detached from the phage bundles, 
which were not found in the non-stained specimen (Figure 3-2d). The possible reason 
for this phenomenon is the low pH of the UA solution made the M13 phage particles 
positively charged. Under this condition, the positive charges on phage particles made a 
perfect negative staining by UA, but at the same time, the positive charges also repelled 
positively charged Au-NPs from phage particles. Captured TEM images should ideally 
reflect the real structures of nanohybrids. Therefore, any stain solution with a pH lower 
than 4.2 is not a good choice for the visualization of Au-NP-phage hybrid.  
3.3.9 Drying Method. 
Drying is also a factor that may affect the appearance of specimens. We tried a 
slow air-drying of the UA stain and kept all other factors the same as the optimal 
condition (0.5% UA, pH=4.5, 10s of staining). We found a lot of small stain crystals 
appearing on the TEM grid. Besides, most Au-NPs were found detached from the phage 
bodies and some phage bundles were broken (Figure 3-5e). Obviously, compared to fast 
drying achieved by using a hair dryer (Figure 3-4 a-b), the slow air-drying of the stain 
encouraged the formation of stain crystals and also interrupted the electrostatic 
interactions between Au-NPs and phage particles.  
  63 
 
3.3.10 Choice of Pre-fixation. 
We performed a pre-fixation with 1% glutaraldehyde (GA) for 20 min before 
negative staining and then stained the specimen with 0.5% UA solution (pH=3.5, 1 
minute of staining, slow drying). As previously mentioned, under these staining 
conditions without pre-fixation, phage bundles should be disassembled and Au-NPs 
should be detached from the phage particles. However, none of the expected 
phenomena happened. Instead, phage bundles were nicely stained and most Au-NPs 
were still attached to phage particles (Figure 3-5f).  The good attachment results from 
the fact that phage particles and Au-NPs were covalently cross-linked by GA molecules 
within the hybrids. Therefore, in the process of staining, either low pH or long staining 
time could not break any of these covalent bonds, leaving the integrated structures of 
the Au-NP-phage hybrids.  
3.4 Discussion 
3.4.1 Mechanism of Negative Staining with UA and PTA. 
Negative staining is achieved when heavy staining ions are repelled by the 
charged groups of the specimen and tracking the trace of the biological molecules. 
These heavy atoms increase electron scattering and improve the amplitude contrast of 
biological molecules. Uranyl acetate (UA, C4H6O6U) is a popular negative stain that has 
been most widely used since 1960. It is used at a pH ranging from 3.5 to 5.5 (the usual 
pH is 4.5) due to its instability at pH higher than 6.0. A molecule of uranyl acetate in 
water is in form of uranyl cation (UO22+). At a pH of approximately 4.5, which is below 
the isoelectric point of most proteins, proteins are positively charged and the charged 
protein residues repel positively charged UO22+, resulting in negative staining [150]. 
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Phosphotungstic acid (PTA, H3PW12O40) is another typical negative stain that usually 
works at a neutral pH. This stain can be employed at a pH range of 5.0 to 8.0, though its 
optimum pH of 6.9. A molecule of PTA in water is in form of ionic PW12O403-. At a pH 
of approximately 7.0, which is above the isoelectric point of most proteins, proteins are 
negatively charged and the charged protein residues repel negatively charged PW12O403-. 
This condition also results in negative staining [150]. However, a certain degree of 
interactions between charged groups of biological molecule and stain ions, especially 
UO22+, may occur, producing positive staining. The main reason for the occurrence of 
positive staining with UA is the small difference between the pI of the protein 
(approximately 5.0) and the pH of the staining solution (usually 4.5).  
3.4.2 Bio-Inorganic Nanohybrids and Negative Staining. 
The conventional negative-staining procedure for regular biological samples 
cannot be applied to bio-inorganic nanohybrids directly. More factors should be 
customized according to each specific hybrid, such as the choice of pH value, staining 
reagent, staining time, and drying method. First, most stain solutions contain divalent or 
trivalent stain ions and some of them have low pH values (e.g., for UA). These stain 
ions and low pH values both contribute to the interruptions of the interactions between 
biological molecules and inorganic nanomaterials. If biological molecules and inorganic 
nanomaterials are covalently linked through a chemical reaction, either low pH or stain 
ions can’t break the covalent bonds [153]. However, if they are linked through 
electrostatic interactions, pH values and stain ions may greatly influence the interactions 
(as shown in the Au-NP-phage system). Therefore, the choices of stains, pH values, 
working concentrations and staining time should be selected carefully. Second, some 
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inorganic nanomaterials and biological molecules are not stable at low pH values. For 
example, hydroxyapatite nanocrystals will be dissolved at a pH lower than 4.0 [154, 155] 
and bacterial flagella are not stable at an acidic pH (low than 5.0). For these materials, 
UA solution is not a good choice due to its acidic working pH (3.5-5.5). Third, 
biological molecules have different isoelectric points, the pH of stain solutions should 
be chosen according to the specific pI of the biological molecules of interest. Fourth, 
some biological molecules only have one type of charged group so not all negative 
stains can be applied to these samples. For example, DNA assemblies only have 
negative charges on their surfaces. In this case, only PTA or neutral stains can be used 
to negatively stain DNA assemblies. Lastly, some inorganic nanomaterials also have 
low contrasts (such as Al2O3 or small nanoparticles) so that they cannot be identified 
when covered by heavy layers of stains. Under this condition, a light staining is 
expected to work better.  
For our Au-NP-phage model system, the formation of the hybrids is based on 
the electrostatic interactions between positively charged Au-NPs and negatively 
charged phage particles. Therefore, the hybrids may not be stable when exposed in stain 
solutions. After the systematic studies of the effects of each factor on the negative 
staining of the hybrids, we found the electrostatic interactions between Au-NPs and 
phage particles could be greatly interrupted when the hybrids were exposed to one of 
the following staining conditions: (1) PTA stain solution (Figure 3-4 c&d); (2) UA stain 
solution for a long time (>1 min) (Figure 3-5 b&c); (3) UA stain solution with a pH 
lower than the pI of phage particles which is ~4.2 (Figure 3-5d); (4) UA stain solution 
with a slow air-drying (Figure 3-5e). The respective reasons are outlined in Table 3-1.  




Table 3-1  A summary of conditions interrupting the association of Au-NPs and 
phage with justification.  
 
 
3.4.3 Choice of Stain and Working pH Based on Specific Bio-Inorganic 
Nanohybrids. 
Choosing the type of stain and its working pH value according to specific bio-
inorganic nanohybrids is the most important step in the negative staining. The choice of 
Conditions interrupting the association of 
Au-NPs and phage 
Reasons 
PTA stain solution 
PW12O403- competed with the -COO- on 
phage particles to bind with positively 
charged Au-NPs 
UA stain solution for a long time (>1 min) 
UO22+ competed with the positively charged 
amine groups on Au-NPs for the binding 
with negatively charged phage particles. So 
the staining time should be as short as 
possible.  
pH lower than the pI of phage particles (~4.2) 
A low pH value of UA solution (<4.2) will 
make the M13 phage particles have a net 
positive charge and thus repel  positively 
charged Au-NPs. 
Slow air-drying 
In a process of air-drying, UA concentration 
will increase and the local pH will decrease. 
A slow air-drying sets the Au-NP-phage 
hybrids into the harsh local environments 
for a longer time and thus interrupts the 
electrostatic interactions between Au-NPs 
and phage particles. 
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the stain and its working pH value should be based on specific bio-inorganic hybrids. 
Specifically, if inorganic nanomaterials or biological molecules are not stable in acidic 
solutions, PTA or other neutral stains will be better for the hybrids. If both materials are 
not pH-sensitive, the driving forces for holding together the biological molecules and 
inorganic nanomaterials should be checked. If both materials are linked by covalent 
bonds through a chemical reaction, both UA and PTA can be used as the negative stain. 
But if the electrostatic interaction is the driving force to hold the biological and 
inorganic components, more factors should be paid attention to during the staining. PTA 
stain is preferred if PW12O403- ions do not greatly interrupt the electrostatic interactions 
between the two components. Otherwise, UA stain will be tested to see if UO22+ ions 
will interrupt the interactions. If yes, it means both PTA and UA stains are not suitable 
for the staining. If no, UA will be selected as the main negative stain for the hybrids.  
Once the negative stain is selected, its working pH value needs to be determined 
next. For PTA, the working pH value should be within the range from 5.0 to 8.0 and 
also higher than the pI value of the biological molecules [150]. For UA, the situation is 
more complicated: first, the specific working pH value should be within the range from 
3.5 to 5.5 [150]; second, if positively charged biological molecules (usually pI>7.0) are 
interacted with negatively charged inorganic nanomaterials through an electrostatic 
interaction, a regular pH of 4.5 will be good for the staining; third, if negatively charged 
biological molecules (usually pI<7.0) are interacted with positively charged 
nanomaterials through an electrostatic interaction, pH=pI+0.3<5.5 (when pI<5.2) is the 
best working pH value. In this case, the slightly negatively charged biological 
molecules and positively charged UO22+ may interact with each other and cause some 
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positive-stain effects to specimens, but the effects are not significant. However if 
5.2<pI<7.0, UA stain with any pH within 3.5 to 5.5 will change the initially anionic 
biological molecules to cationic, resulting in the detachment of positively charged 
inorganic nanomaterials from biological molecules. In this work, positively charged Au-
NPs and negatively charged phage particles (pI=4.2) are stable in acidic solution, and 
they interact with each other through an electrostatic interaction which could be greatly 
interrupted by PW12O403- ions but not UO22+ ions.  
With the above information, if pH < pI, the interactions between biological and 
inorganic components will be interrupted. If pH>pI+0.3, the pH will cause severe 
positive-staining effects to the sample which may darken the biological structures in 
certain areas. If pI<pH<pI+0.3, the biological sample may not have enough charges on 
their surfaces for electrostatic interactions and negative staining. Thus we can easily get 
the conclusion that UA solution with a pH=pI+0.3=4.5 is the optimal condition for 
staining Au-NP-Phage hybrids (Figure 3-4a&b).  A best pH value of 4.5 is reasonable 
because it could not only favor the electrostatic interaction and but also reduce the 
positive-staining problems. 
3.4.4 Choice of Stain Concentration Based on Specific Bio-Inorganic 
Nanohybrids. 
The concentration of the stain is another important factor that may affect the 
appearance of the specimens. A high concentration of stain solution (>1%) is not 
recommended for two reasons. First, highly concentrated stain ions may accelerate the 
departure of inorganic nanomaterials from biological molecules. Second, heavy layers 
of stain may cover most inorganic nanomaterials so they will be unrecognizable under 
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TEM (Figure 3-5a). Therefore, a low concentration (0.5%) of the stain will produce a 
better staining for bio-inorganic nanohybrids.  
3.4.5 Choice of Fixation Based on Specific Bio-Inorganic Nanohybrids 
Pre-fixation has been used in negative staining in some cases. Its function is to 
covalently cross-link intra- and inter-molecules to prevent drastic alterations or damages 
in negative staining. However, the fixation should not form inter-particle cross-links, 
otherwise, artificial structures may appear. The most useful fixative in biological 
electron microscopy is glutaraldehyde (GA) which covalently cross-links nucleophilic -
NH2 groups. For the bio-inorganic nanohybrids, fixation should not be performed if 
either biological molecules or inorganic nanomaterials are covered by -NH2 groups. 
Otherwise, inter-particle cross-linking will occur and the initial appearance of the 
hybrids may be changed. In our Au-NP-phage system, both phage particles and Au-NPs 
are covered by -NH2 groups, so GA is not suitable as a fixative for the negative staining. 
GA molecules may cross-link neighboring phage particles so that phage bundles can be 
observed after fixation even without Au-NPs. They may also cross-link NH2-covered 
Au-NPs with phage particles. It would be difficult for us to figure out whether the cross-
linking between Au-NPs and phage particles were due to electrostatic interactions or 
fixations.  
3.4.6 Why Rapid Drying is better 
Slow air-drying is a popular and simple strategy for the drying of stains, but it 
also has two main limitations. First, since hydrated crystals tend to grow by slow 
evaporation, slow drying of the stain after negative staining can only encourage the 
formation of stain crystals instead of amorphous stain deposit which is required for the 
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desired resolution. Second, in the process of drying, salt concentration will increase and 
the local pH will also decrease (e.g., for UA) or increase (e.g., for PTA). Such changes 
can influence the final appearance of the specimen. A slow drying will put the specimen 
into a harsh local environment for a longer time and has greater chances to influence the 
appearance of the specimen. Therefore, a rapid drying by a hair drier may improve the 
negative staining.  
3.5 Conclusion 
TEM characterization of negatively stained bio-inorganic nanohybrids is a 
popular and simple technology for viewing such nanostructures. We chose 
bacteriophage-gold nanoparticle hybrid as a model to systematically study the effects of 
each factor on the negative staining of the nanohybrids. The best staining conditions for 
this hybrid system include the use of 0.5% UA solution (pH=4.5), a staining time of 10 
s, and a rapid drying of the stains. The experimental results suggested that each factor 
could influence the final appearance of the stained specimens and the best choice of 
each staining factor should be customized to the specific bio-inorganic nanohybrids. 
The effects of each factor on the negative staining of the nanohybrids were discussed 
and a general method about how to select each staining factor was summarized. This 
work provides useful information for the negative staining of bio-inorganic 
nanomaterials, which will greatly help research in the fields of bionanotechnology and 
nanomaterials.  
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Chapter 4: A novel stem cell binding motif identified by phage 
display promotes non-viral gene delivery to stem cells 
4.1 Introduction 
Gene delivery is a promising and mostly studied method for treating 
traditionally incurable diseases. Although virus based delivery strategies have shown 
high delivery efficiency, moral controversies and potential problems of using viral gene 
vectors have led to a dramatic development of non-viral gene delivery[156]. Recently, 
mesenchymal stem cell (MSC) has become an excellent target candidate for gene 
therapy due to its multipotency, self-renewing ability and ease of preparation[157]. 
MSCs with delivered gene inside can be injected to the damaged tissue or organ and 
express specific functional proteins for tissue or organ recovery. However, a relatively 
low delivery efficiency of non-viral vectors has become a major obstacle for applying 
the strategy into practical use. Recently, it has been found that conjugating target-
binding peptide onto the delivery system can greatly improve the delivery 
efficiency[158]. Therefore, to find a reliable technique that can identify MSC-targeting 
peptides has become a promising solution to increase the gene delivery efficiency for 
the MSC based gene therapy. 
Phage display technology has matured to be a powerful tool to identify target-
binding peptide through a process of affinity selection[10, 11, 159]. Various target-
binding peptides have already been identified, including peptides that can specifically 
bind to proteins, inorganic materials, and living mammalian cells[159-164]. The 
principles of phage display technique have been reviewed elsewhere[23, 165-167]. 
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Briefly, a phage-displayed random peptide library (also called phage library) is allowed 
to interact with a target (e.g., a protein or a cell), and then the nonbinding phages are 
washed away from the target, leaving the binding phages bound to the target. The 
binding phages are then eluted from the target and amplified by infecting bacteria to 
form an enriched phage-displayed peptide population, which can be treated as a new 
library to interact with the target again. This process is called biopanning and usually 
repeated for several rounds to identify the peptides with binding affinity against the 
target. We employed this matured phage display technique to identify MSC-targeting 
peptide for increasing the gene delivery efficiency towards MSCs. A possible scheme of 
applying the work in this research is shown in Figure 4-1. Efficiently recognizing MSCs 
by random phage library mostly depends on the distribution of cell surface receptors. A 
variety of nanoparticles and nanovehicles that are non-viral vector candidates have been 
reported to be uptaken by cells via receptor mediated endocytosis. Therefore, an 
understanding which type of cell surface receptors interacts with MSC binding peptide 
would provide hints for studying the ligand-receptor interactions of MSC and improve 
the transfection efficiency of non-viral gene delivery to MSCs.  It may also help the 
study of proteomics.  
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Figure 4-1 Scheme of applying phage display and mesenchymal stem cells to 
customized therapy. 
 
In this work, we conducted affinity selection based on phage display on primary 
rat MSCs. The phage library we used is Ph.D.-12 phage library from New England 
Biolabs. The specific binding peptide HMGMTK was identified from phage display 
based cell panning and further bioinformatics analysis. It was confirmed by 
immunological fluorescence imaging. We further analyzed the selected peptide under 
bioinformatics and found that the peptide HMGMTK shows a high similarity to the 
previously proposed signaling region of a chemokine CX3CL1, the ligand of 
CX3CR1.[168, 169] For testing the effect and future uses of selected MSCs binding 
peptide in non-viral gene delivery, we built up a multifunctional nanoparticle that is a 
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complex of the EGFP report gene, Liposome/Protamine/DNA complex (LPD), specific 
binding peptide HMGMTK (named PA). Nuclear localized signal (NLS) motif 
(DPKKKRKVDPKKKRKVDPKKKRKV) [170] was also introduced to facilities the 
transgenic DNA to penetrate the nuclear membrane and enter cell nucleus. The resultant 
complex vector (termed as LPD+PA+NLS in this article) showed highest transfection 
efficiency among commercial vector LipofectamineTM 2000 (Invitrogen, USA), LPD 
without any peptides and LPD with control peptide having no affinity to MSCs as well 
as LPD with PA. Meanwhile, cytotoxicity evaluation result showed that LPD+PA+NLS 
complex did not show obvious cell toxicity and influence on the differentiation potential 
of rMSCs while increasing gene transfection efficiency to MSCs.  
 
4.2 Experimental Procedure 
4.2.1 Materials 
All the cell culture reagents were obtained from Gibco BRL unless otherwise 
stated. All chemicals were obtained from Sigma Chemical Co. unless otherwise stated. 
The Ph.D.-12 Phage Library, where there are billions of M13 phage particles with each 
particle displaying a random linear 12-mer peptide on the C-terminus of minor coat 
protein (pIII), was a product of New England Biolabs. Plasmids pT2 and pSB are kindly 
provided by Dr. Perry Hackett, University of Minnesota.  
4.2.2 Primary rat mesenchymal stem cell isolation and culture 
The primary rat mesenchymal stem cells (rMSCs) were prepared by following 
previous literatures [171]. The complete culture medium was Dulbecco’s modified 
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eagle medium (DMEM low glucose) supplemented with 100 IU/ml penicillin and 100 
g/ml streptomycin, and 2 mM L-glutamine, and 10% v/v fetal bovine serum (FBS). NIH 
guidelines for the care and use of laboratory animals have been observed. Briefly, male 
Sprague-Dawley rats weighing 70-150g were killed by CO2 asphyxia and the bone 
marrow was harvested from the hind limbs. Then marrow cells were flushed out 
strongly by a 27-gauge needle attached to a 10 ml syringe containing complete media 
and collected in a 10 ml tube on ice. After filtering the cell suspension through a 70 mm 
mesh to remove any bone debris, bone marrow cells were cultured in a culture dishes 
and incubated at 37°C with 5% CO2 for 3 hours. The non-adherent cells, which are not 
mesenchymal stem cells, were removed by changing the medium and replaced with 
fresh complete medium. The medium was re-changed after an additional 8 hour of 
culture. The typical adherent spindle-shaped cells appeared on the third day and reached 
65-70% confluence within 2 weeks. Then the cells were washed by phosphate-buffered 
saline and treated with 0.5ml 0.25% trypsin/1mM EDTA for 2 min at room temperature 
to further remove loosely bound non-MSCs. The culture medium was changed every 3 
days regularly and cells typically reached confluence and sub-cultured in 7 days.  
4.2.3 Selection of rMSC-binding peptide from a phage-displayed random 
peptide library: Biopanning 
Biopanning against primary rat MSCs was carried out according to 
manufacturer’s protocols and previous literatures [172]. Primary rMSCs within 3 
passages were seeded on 6-well plates in the density of 1~1.5×105 cells/well 1-2 days 
before panning and used for experiments when reaching ~90% confluence. Before the 
panning procedure, the complete cell culture media was replaced by serum free media 
  76 
 
and cells were incubated for 2 hours at 37°C to clear cell surface receptors. The phage 
panning solution was prepared by diluting the original phage library to the final 
concentration of 1×109 pfu/ml with PBS and 0.1% w/v BSA and supplementing with 
10µl 10mM chloroquine and 40µl protease inhibitor without EDTA (25×, Roche) and 
making the final volume to 1ml. The phage panning solution was applied on empty 6-
well cell culture plate to eliminate any plastic-bound phages before it was allowed to 
interact with MSCs. The serum free media was removed and the cells were washed by 
PBS with 0.1% BSA once. 1×109 pfu/ml of pre-cleared phage panning solution was 
incubated with cells in the 6 well plate (1ml panning solution per well) for 1 hour at 
37°C. After incubation, the supernatant was aspirated and the cells were washed four 
times at room temperature by PBS with 0.1% BSA for 5 min per wash to remove any 
unbound phages. Cell surface binding phages that were weakly associated to the cells 
were eluted by 1ml 0.1M HCl-glycine + 0.9% NaCl (PH 2.2) for 5 min, followed by 
neutralizing with 1.5M Tris-HCl (PH 8.8). Then cells were scraped off the plate and 
lysated by free-thaw disruption in order to release any tightly bound phages or phages 
that may internalize into the cells. The output phages were amplified by infecting the 
host Escherichia coli ER2738 and titered each round to ensure that the equal amount of 
input phages (1×109 pfu) were used in each round. This panning procedure was repeated 
four times. The output phages of the final fourth round were sequenced to get the high-
affinity peptide sequences to primary rMSCs. The output to input ratio (O/I) was 
calculated as the index for the recovery of phages from each round of panning on 
rMSCs. 
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4.2.4 Phage titering, amplification and purification 
The phage amplification and purification was done by following manufacturer’s 
manual. Briefly, 20 ml of E. coli host ER2738 prepared from the overnight culture was 
infected by the output phage of each round and incubated with vigorous shaking for 4.5 
hours at 37°C. Then the infected culture was centrifuged twice at 12000 g for 10 min at 
4 °C. The top 80% of the supernatant was transferred to a fresh tube and 1/6 volume of 
20% PEG/2.5M NaCl was added to allow the phage to precipitate at 4°C overnight. The 
PEG precipitate was centrifuged at 12000g for 15 min at 4°C twice. The white phage 
pellet was suspended in 1 ml of TBS and transferred to a micro-centrifuge tube to spin 
at 14000 rpm for 5 min at 4°C to pellet residual cells. The supernatant was transferred 
to a fresh tube and re-precipitated by adding 1/6 volume of 20% PEG/2.5M NaCl for 1 
hour or overnight. The further purified phage pellet was obtained by centrifuging at 
14000 rpm for 10 min at 4°C and suspended in 200 µl of TBS. This suspension included 
the amplified phages, which would be used as input phages for successive panning 
round after proper dilution. The input, output, and amplified phages were titered as 
described in the manufacturer’s protocol. The E. coli host ER2738 was cultured to reach 
mid-log phase, OD600 ~ 0.5 and 200µl of the culture was dispensed into microfuge tubes 
for phage infection. A series of dilutions of phages was prepared in LB to 1ml final 
volume. 10 µl of each phage dilution was added to each tube of host cells in mid-log 
phase with vigorous vortex and incubated at room temperature for 5 min. The infected 
cells were plated on pre-warmed LB/IPTG/Xgal with top agar assistance and incubated 
overnight at 37°C. The number of blue plaques on plates was counted next day and 
multiplied by the dilution factor to get phage titer in plaque forming units (pfu) per 10µl. 
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The titering plate of the unamplified output phage from the final round of panning that 
have approximately 100 plaques was used to pick individual plaques for sequencing.  
4.2.5 Statistical Analysis 
All the biopanning data were analyzed by the bioinformatics tool — RELIC 
program [173]. The probability of each selected sequence was calculated by INFO 
program in RELIC server and compared with that of random phage library. Only the 
sequences having higher probability to original phage library were used for comparing 
with several known ligands for MSCs. The similarity scores of selected sequences to 
known ligands that bind to various cell surface receptors present or absent on rMSCs 
were obtained by using RELIC-MATCH program and plotted over the amino acid 
position of known ligands to find the best match.   
4.2.6 Fluorescence imaging using synthetic peptide 
Peptide HMGMTK was chemically synthesized and conjugated with fluorescein 
isothiocyanate (FITC). A FITC-conjugated scramble peptide GTMHKM was also 
synthesized as control. FITC molecules were conjugated to the peptides during 
synthesis through Ahx as spacer to minimize any possible steric hindrance. Primary 
rMSCs were plated on the glass coverslips in a 6 well plate (Falcon). Same as in the 
phage screening, the cell surface receptors were pre-cleared by incubating the cells with 
serum-free media for 2 hours. The precleared cells were incubated with FITC-
conjugated peptide diluted by PBS/0.1% BSA in a proper concentration for 1 hour at 
37°C.  Then the cells were washed three to five times with PBS, fixed with 4% 
paraformaldehyde for 15 minutes at room temperature. The cell nuclei were 
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counterstained with DAPI. The cells were observed under fluorescence microscopy 
(Nikon). The assay was performed independently for three times. 
4.2.7 The construction of Liposome/Protamine/DNA complex (LPD) 
To construct the LPD, we used a two-step packaging technology employing a 
multi-layering method (13, 14). First, the DNA was packaged into a condensed core via 
electrostatic interactions with protamine. The targeting peptide with slightly positive 
potential was also added and interacted with the plasmid to form a negative charged 
particle. Second, liposome protamine/DNA lipoplexes (LPD) were prepared through 
membrane fusion of neighboring phospholipid bilayer of liposome, triggered by the 
assembly of positively charged DOTAP/DOPE/Chol liposome around the negatively 
charged core. The morphology of LPD was observed using TEM (Carl Zeiss, Germany). 
One drop of polyplex was placed on a copper grid and stained with 2% uranyl acetate 
for 3 minutes. The grid was allowed to dry further for 20 min and was then examined 
with the electron microscope. 
4.2.8 Conjugation of targeting peptide to LPD 
The reduction of cysteine residues in the targeting peptide was first performed. 
Briefly, 5 mL peptide (100 µM, PBS, pH7.5) was first mixed with tris(2-carboxyethyl) 
phosphine (TCEP; 2 mM) with a 1:2 ratio of peptide/TCEP. The reaction was allowed 
to proceed at 37 °C for 2 h. A 10 µL DSPE-PEG2000-MAL (10 mM) stock solution 
was reacted with 5 mL (100 µM) of the reduced peptide in PBS buffer (pH 7.5), 
corresponding to 5:1 molar ratio of reduced peptide to maleimide groups. The 
conjugation reaction was carried out for 3 h at room temperature. Conjugated peptide-
PEG-DSPE was purified by dialysis (500 Da membrane).  
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4.2.9 Preparation of Targeting LBNs 
To obtain targeting liposomes, the insertion of the peptide-conjugated lipid 
(peptide-PEG-DSPE) into liposomes was performed by employing a post-insertion 
technique. For this purpose, liposome (20 mM, as denoted by DOTAP in liposome) in 
water solution was incubated with a various amount of peptide-PEG-DSPE for 1 h with 
vortexing. The resultant solution was kept at 60 °C for 1 h. As a result, the conjugates 
became attached to the outer lipid layer of the vesicles via hydrophobic DSPE domain.  
4.2.10 Transfection Efficiency 
For the transfection experiments, rMSC cells were seeded in the 24-well plate at 
a density of 1×105 cells/well and incubated overnight. The mass ratio of pT2/EGFP and 
pSB11 was 2:1 as in the earlier report.[174] The LPDs with various peptides in low 
glucose DMEM were added, and LipofectamineTM 2000 (Invitrogen, USA) was used as 
a control. The cells were incubated for 4 h at 37˚C. Then, the transfection medium was 
replaced with fresh culture medium and the cells were further incubated for 72 hrs. 
Inverted fluorescent microscope was also used to observe the GFP expression. The 
transfected cells was digested by trypsin and fixed in a 4% paraformaldehyde for 30 
min at 4˚C to prepare single-cell suspensions. The percentage of cells positive for GFP 
was determined by flow cytometry (Becton-Dickinson Biosciences, Franklin Lakes, NJ, 
USA) by setting a gate according to the control and 10,000 cells were evaluated in each 
experiment. 
4.2.11 Cytotoxicity Assay 
Cytotoxicity of LPD was assayed using MTT assay. Briefly, rMSC cells were 
seeded at 10,000 cells per well in 96-well plates. One day later, the cells were 
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transfected by LPD with various peptides at different liposome concentration. The 
LipofectamineTM 2000 was used as the control. The cells were incubated for another 12 
h at 37˚C. Then, the medium was replaced with 80 µl of fresh medium without serum 
and 20 µl of MTT (5 mg/ml) (Sigma-Aldrich Co. LLC, USA) solution, and incubated 
for an additional 4 h. Subsequently, the medium was removed and 100 µl of DMSO was 
added. The absorbance at 570 nm was measured by using a microplate reader.  
 
4.3 Results  
4.3.1 Identification of peptides that can specifically bind with primary rMSCs 
by phage display 
Primary rat MSCs-targeting peptides were identified by applying PhD-12 phage 
library to primary rMSCs for 4 rounds of panning. All the input and output phages were 
titered to monitor the panning procedure. The ratio of the titer of output/input (O/I) was 
calculated to estimate the recovery rate of phages from each panning round. A 
significant increase in the titer number was observed (Figure 4-2), suggesting an 
enrichment of phages that can bind to the primary rat MSCs with high affinity.  
 














Figure 4-2 Recovery of phages after affinity selection on primary rat MSCs (O/I ratio) 
 
 
After 4 rounds of panning, we picked total 82 individual clones with 78 
sequences identified (shown in Table 4-1). The decreasing of the diversity of the 
sequences obtained from several rounds of selection is an important indicator of affinity 
selection. Here, RELIC/POPVID program was applied to estimate the sequence 
diversity of a combinatorial peptide library. Selected peptides with the binding affinity 
against rMSCs should have a diversity value lower than randomly selected peptides 
Rounds phage recovery (O/I ratio) 
1 1.0 × 10 -7 
2 6.1 × 10 -7 
3 1.0 × 10 -6 
4 1.3 × 10 -5 
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from the initial library. We calculated the diversities of both affinity-selected peptides 
and random peptides selected from the initial parent library by using the 
RELIC/POPVID program. Our affinity selected peptides yielded a diversity value of 
0.005191 ± std.0.005141 (for the output phages of the 4th round of affinity screening) 
whereas the 78 randomly selected peptides from the initial parent library yielded a 
diversity value of 0.036576 ± std. 0.018990. Compared to randomly selected peptides, 
affinity selected peptides have a significantly less diversified population. This fact is an 
evidence for the successful selection of peptides with binding affinity against 
immobilized rMSCs during the biopanning process according to the principle of 
RELIC/POPVID program.  
Although the drop of sequence diversity is an indication of successful phage 
panning, it is not a characteristic of individual peptides or peptide distribution. The 
biological steps of phage amplification may introduce unexpected distortion and result 
in counterfeit drop of sequence diversity. This is because that some sequences may be 
more favorable and thus corresponding phages will grow faster than other members in 
the phage pool. In order to evaluate whether the distribution of the sequences from 
affinity selection (signal) is distorted by the noise introduced by the biological steps of 
phage amplification, RELIC-INFO program was used to measure the probability of a 
peptide sequence and their occurrence after phage screening process. In this program, 
the probability of any one peptide in the library is defined by a parameter called 
Information Content = - ln(P) where P is the product of the probability of each amino 
acid at each position, a.k.a. P = P1P2P3•••P12. A peptide with smaller information 
content would be more possible to be observed because of amplification process but not 
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affinity binding. The principle of phage screening is enriching the phage displaying 
targeting peptide while decreasing the peptide diversity due to the affinity binding. 
Therefore, an enrichment of peptides with higher information content is expected for 
phage screening. In other words, if we plot the information content versus their 
occurrence in the pool, a result of phage screening is trustable when a positive shift 
towards higher information content is observed comparing with that of parent random 
phage library in the normalized plot (Figure 4-3). As expected, an obvious shift of the 
information content plot towards the higher information content was observed, 
suggesting the high reliability of the selection result of phage screening against rMSCs. 
Moreover, more reliable peptides can be picked out based on the information of Figure 
1B. A cutoff value can be defined as 34.3 indicating significant improvement of the 
reliability of selected sequences compared to random library sequence, represented by 
dash lines on Figure 4-3. The peptides with information content higher than the cutoff 
value would show up on the right side of dash line. These peptides are more reliable 
that those lower than the cutoff values because their occurrence in library were high 
even they are more improbable to survive through amplification process (high 
information content). Their occurrences are more possible due to affinity binding rather 
than natural amplification, in other words, more reliable. Thus, we will only use these 
more reliable sequences for proteomic analysis to ensure its validity.   
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Figure 4-3  Plot of the information content of peptide sequences calculated by RELIC-
INFO program. RELIC-INFO program was used to measure the probability of a peptide 
sequence by random selection or by affinity selection. In this program, the probability 
of any one peptide in the library is defined by a parameter called Information content= - 
ln (P) where P is the product of the probability of each amino acid at each position, 
a.k.a. P = P1P2P3•••P12. The red curve with round dots is the information content of 
selected sequences from affinity selection on rMSC. The black curve with square dots is 
the information content of originally random Ph.D.-12 library sequences used as 
control. The dark blue dash line shows the cutoff indicating significant improvement of 
the reliability of selected sequences compared to random library sequences. 
 
In summary, the validity of affinity selection against primary rMSCs by phage 
display is supported by the results shown above: (1) the phage recovery rate was 
increasing as phage panning was going on. This indicated that the phage pool was 
enriched with sequences exhibiting strong affinity binding to the target and thus could 
survive from the vigorous washing in the panning step; (2) the sequence diversity of 
phage pool was decreased because the non-specific sequences were eliminated by 
subsequent phage panning process; (3) the affinity selected sequences were the peptides 
which are less likely to survive from natural selection.   
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After ensuring the reliability of phage panning results, several homological 
peptides were identified and underlined in Table 4-1 after careful analysis. For example, 
PSL (P/T/K), T(L/V)P, LGL were showed several times in the selected sequences, but 
the most frequent one among them is (A/H)MG(M/L)(T/L/S/R)(K/T/S) which is 
marked in bold in Table 4-1. Moreover, the HMGMTK peptides showed twice with the 
exact same sequence, which suggested that it might be the most possible binding 
peptide to rMSCs. In addition, the two peptides HMGMTKIKYFPL and 
HMGMTKGNYSAL that have the most possible binding peptide are both having 
information content higher than the cutoff value, further supporting the reliability of 
HMGMTK peptide. Therefore, we successfully identified one possible and reliable 
binding peptide HMGMTK after bioinformatics analysis. 
  




Table 4-1  Peptide sequences identified by phage display. Homological motifs were 
underlined and the most frequent one (A/H)MG(M/L)(T/L/S/R)(K/T/S) were also 









HNPIGFDLNNPE DSPNMRSWQKSE NHIPSLPKHQSL ITPDHRLLGLLY 
YTYPLSKMKNVV WSTQVPIRISPA SSHEVLGLPKIR FQSYNQARNPTI 
NWQDLRNMNAPH ILAGQMAYRQTH SFFNIYEPTGLT KTSAAMMHSMSL 
GDNQKTDYSPKP NTVDTHRHQGSK GHTHEAPRVMRL HTLPPLMTGLRT 
KIEEATHRQVRE NRPDSAQFWLHH GAMHLPWHMGPL SAGANLTKTAYL 
HAVATLKETAKV SHDNHGTAYNPG NIPKSDLAAYNA VYQTGTATNDPP 
HMGMTKIKYFPL SHNSTFGQLTAR VDKTTDSFRSVM ANSHGLRANPTP 
QALLEGNAKGGN SSYYPQLTAHRF DAISLPMPSKRS NPSSSQSLWAHR 
SWIPHPRWSPHH VTWQKGLNSQVG IVRPNAHNLPVR DSPSMKSYAWFS 
TDNPEWMRTHNT HMGMTKGNYSAL AINGLSSLNTRP NAASTVHSPDRL 
CEFPRSWDMESN SNAYSGPAGAPL TPSLKHHMKTQN APFAQLPSVARS 
AHKYAIHYAFPW SWMPHPRWSPQH YTFPARPHLDLH TDLARETSNNSP 
IPTKHWIQTKLD DGQEKGHQVLNR GPMHLPWHMGTL LESHYTQASYTQ 
TETYQPIFRMKT ISAPYAKQHLSK KLHISKDHIYPT WPHPSLTVPWLP 
STSSYSEPIWMK GGNTEWGNNTRH APFRTTQLPNGM YGPPAPMTLLTV 
ATADPGTYNSEA DHHTRPDNIRIR TPQFFKSLGSPM NTWMTEKILSPQ 
NDGMTGGWNVRQ FVSTTQTHYRGE TTSLYLKKAFAA SPLTIPSMAYGQ 
WQGGSQNSTHQR TEASSMLKNPHA TTIADSHRGLRQ RVPAVQPGPPPY 
DAMTTYKSLQRI  NASMAVKVFSPL  
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4.3.2 Bioinformatics analysis suggests that CX3CL1-CX3CR1 axis may 
mediate binding between the identified peptide, HMGMTK, and rMSCs. 
We further dig into the possible mechanism that is responsible for high affinity 
of identified peptides from phage display. Although no surface antigen has been clearly 
reported as a characteristic MSC marker, many cell surface receptors are expressed by 
MSCs including phenotypic receptors, growth factor receptors, chemokine and cytokine 
receptors, cell-matrix receptors, etc. (Table 4-2) [175-178]. We selected several cell 
surface receptors that are present (MSC+) and absent (MSC-) on the surface of MSCs 
and their corresponding ligands to do the proteomics analysis of our selected sequences. 
For example, stro-1 antibody was shown to recognize the cell surface antigen present 
only on MSCs. SB-10 is an antibody of CD166. So we used stro-1 and SB-10 to 
compare with our selected sequences. Similar treatment was applied to SDF-1 (a ligand 
of CXCR4, also called CXCL12), CXCL6 (a ligand of CXCR6) and CX3CL1 (a ligand 
of CX3CR1). We also compare our sequences with some cell adhesion molecules such 
as ICAM-1 and VCAM-1. Fibronectin as the most common binder of integrin was also 
tested in this alignment. As comparison, two ligands that bind to receptors absent on the 
surface of MSCs were also aligned with our sequences. One is LYN, which is a ligand 
of CD45, and the other one is CCL11, a ligand of CCR3. 
  
  89 
 
 
Table 4-2  The cell surface molecular profile of mesenchymal stem cells 
 
RELIC-MATCH program was used to align our reliable affinity-selected 
sequences with many known ligands binding to cell surface receptors that MSCs could 
or could not express. As stated previously, the sequences having higher information 
content than the cutoff value 34.3 would be more reliable than those lower than cutoff 
value. So in order to obtain convincing peptide alignment results, we only use more 
reliable sequences (information content higher than 34.3) to the proteomics analysis. 
Then we plotted the similarity score of each amino acid versus amino acid position to 
find potential MSC binding peptide independently by RELIC-MATCH (Figure 4-4). A 
cutoff value of similarity score 10 was set and the area exhibiting higher similarity score 
than cutoff value was marked by arrows in Figure 4-4. Higher average similarity score 
of ligands binding to MSC positive receptors could be noticed compared to that of MSC 
negative receptors. And most areas with scores higher than the cutoff value were in 
Molecules present (MSC+) Molecules absent (MSC-) 
Phenotypic receptors 
Stro-1 antibody CD 34 
CD 73 CD 45 
CD 90 CD 25 
CD 105 (Endoglin) CD 14 
CD 166 (ALCAM) CD 4 
Chemokine receptors 
CCR1, 2, 4, 6, 7, 9, 10 CCR3 
CXCR1, 2, 4, 5, 6  
CX3CR1  
Cell adhesion molecules 
ICAM-1, VCAM-1  
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MSC positive category. It is also noteworthy that the highest similarity score reaching 
nearly 37.5 belonged to the alignment between reliable selected sequences and CX3CL1, 
a chemokine that binds to CX3CR1. Moreover, further investigation found that this high 
similarity score is caused by the best match between the putative binding site of 
CX3CL1 and HMGMTK peptide which has been believed to be the most possible MSC 
binding peptide based on other analysis (Figure 4-5). This finding further solidified our 
belief that HMGMTK is the MSC binding peptide and its binding may be mediated by 
CX3CL1-CX3CR1 axis.  
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Figure 4-4  The similarity score of reliable selected sequences and several known 
ligands that interact with both MSC positive and negative surface receptor. Stro-1, 
SB10, CX3CL1, SDF-1, CXCL16, ICAM-1, VCAM-1, fibronectin are the known 
ligands that could bind to the MSC expressed cell surface receptors (MSC+). LYN 
and CCL11 are two examples of known ligands binding the receptors that MSCs 
could not express (MSC-). A cutoff value 10 was set for indicating the significant 
similarity by arrows.  
 
 
mapsqlawllrlaaffhlctllagqhlgmtkcnitchkmtspipvtllih   50 
                         HMGMTKIKYFPL              
                    ILAGQMAYRQTH                   
                         HMGMTKGNYSAL              
                 ISAPYAKQHLSK                      
 
Figure 4-5  Best match position in the full length CX3CL1 with reliable selected 
sequences aligned by RELIC-MATCH program. This match position in CX3CL1 
is localized in its N-terminal chemokine domain (CX3CL1-CD) which may 
suggests the exact binding site of CX3CL1.  
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4.3.3 Synthetic peptide HMGMTK showed higher binding affinity to primary 
rMSCs compared to scrambled peptide as control and its affinity binding could 
be competitively inhibited by engineered phages displaying HMGMTK peptide 
To experimentally prove that HMGMTK is the MSC binding peptide, we 
conducted the fluorescence imaging by fluorescein-conjugated synthetic HMGMTK 
peptide. We treated the peptides with rMSCs in the same condition as during phage 
screening process to keep the cell condition consistent. And a scrambled peptide 
GTMHKM with the same types of amino acid but different sequences comparing to 
HMGMTK was also chemically synthesized and conjugated with fluorescein as control. 
Fibroblast cells and cancer cells MCF-7 were cultured and treated as control cells for 
testing peptide specificity. As expected, rMSC incubated with HMGMTK peptide 
showed stronger fluorescence intensity than that with scrambled peptides, indicating 
stronger affinity binding of HMGMTK (Figure 4-6A, B). Meanwhile, no fluorescence 
was observed in Fibroblasts and MCF-7 cell samples (Figure 4-6E, F), which confirms 
the specificity of peptide HMGMTK. To further confirm this result, we amplified the 
phage clone displaying HMGMTK as the competitor of synthetic HMGMTK peptide. If 
the stronger fluorescence intensity observed in cells treated with HMGMTK peptides 
was indeed induced by the strong affinity binding between the peptide and cell, the 
phage displaying HMGMTK should be able to bind to the cells preferentially and then 
block the cell surface for subsequent binding with synthetic HMGMTK peptide like 
competition inhibition. We observed that the fluorescence intensity was dramatically 
decreased in the samples treated with phage first and then synthetic peptide next (Figure 
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4-6C, D). This is consistent with our expectation and further confirms that HMGMTK 
is a MSC specific binding peptide.  
 
 
Figure 4-6  The fluorescence imaging showing the higher affinity of peptide 
HMGMTK compared to scrambled peptide as control. A) rMSCs after interacted 
with FITC-HMGMTK peptide; B) rMSCs after interacted with FITC-scrambled 
control peptide; C) rMSCs after treated with phage displaying HMGMTK first 
and then interacted with FITC-HMGMTK peptide; D) rMSCs after treated with 
phage displaying HMGMTK first and then interacted with FITC-scrambled 
peptide. E) fibroblasts incubated with FITC-HMGMTK peptide; F) MCF-7 cells 
incubated with FITC-scrambled peptide. Cell nucleus was stained by DAPI. Scale 
bars in A, B, C, and D are 50µm and in E and F are 100µm. 
 
4.3.4 Integrating MSC-binding peptide HMGMTK and NLS peptide into 
Liposome/Protamine/DNA (LPD) nanocomplex showed increased transfection 
Efficiency but remain low cytotoxicity 
To investigate the targeted delivery efficiency of the peptide HMGMTK, we 
performed the transfection efficiency study using LPD system bearing the synthetic 
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targeting peptide HMGMTK. EGFP reporter gene was used as the transgene model. To 
construct the LPD, we used a two-step packaging technology based on a multi-layering 
method [179, 180]. The constructed LPD particles were evaluated under TEM (Figure 
4-7). To further enhance the nuclear translocation efficiency of transgene, three-fold 
reiterated nuclear localization signal (NLS) motif of SV40 T large antigen with a 
sequence of DPKKKRKVDPKKKRKVDPKKKRKV was introduced to promote the 
gene expression of LPD [170]. We integrated both the selected peptide HMGMTK 
(named PA) and previously reported NLS peptide into LPD systems to build an 
effective gene delivery carrier (we labeled it as LPD+PA+NLS). 
                                                   
Figure 4-7  TEM image of LPD particles. 
 
 
EGFP expression after transfection via LPD+PA, and LPD+PA+NLS at 
different pDNA-peptide mass ratio was examined, while LPD only (i.e., the LPD with 
no peptide conjugated), and LPD+control peptide were served as control. We used 
fluorescence microscopy, by which the intensity of fluorescence could be used to 
represent EGFP expression level, to determine the transfection efficiency. The result 
  95 
 
showed that (1) LPD incorporating targeting peptide only (LPD+PA) showed greatly 
enhanced transfection efficiency compared to commercial vector Lipofectamine, LPD 
without peptide and LPD with control peptide, which means selected rMSCs binding 
peptide HMGMTK could facilitate gene transfer to rMSCs; (2) LPD+PA+NLS further 
increases efficiency compared to LPD+PA, which suggests that integrating NLS into 
the system would help LPD+PA bring target gene to cell nucleus and thus further 
increase gene-of-interest expression. We could draw the conclusions from the result that 
the binding ability to rMSCs of identified peptide HMGMTK was confirmed; On the 
other hand, involving rMSC-binding peptide HMGMTK into LPD system could 
enhance the efficiency of non-viral gene delivery.  
 
 
Figure 4-8   Transfection efficiency of LPD with peptide HMGMTK and NLS 
peptide in rMSC. GFP expression level in rMSCs due to the delivery of EGFP 
reporter gene by LPD only (a) and LPD+PA+NLS (b) was visualized by 
fluorescence imaging. Scale bar: 100 µm.  
 
To further verify the feasibility of using the novel LPD-peptide complex as a 
gene delivery vector, we conducted MTT assay to test its in vitro cytotoxicity. We set 
the threshold to judge cytotoxicity at 60% viability, which means when cell viability 
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below 60% after a trial we will consider the amount of substance used in the trial as cell 
toxic. Various concentrations of LPD+PA+NLS, LPD and LipofectamineTM 2000 after 
12 h incubation with rMSCs at 37˚C were parallel tested in this experiment (Figure 4-9). 
We found that LipofectamineTM 2000 would be considered as cell non-toxic (cell 
viability higher than 60%) only at relatively low dosage, 20mM. Nevertheless, both 
LPD and LPD+PA+NLS can reach 60 and 50 mM when they can still be judged as safe 
to cells. This fact demonstrates that LPD-peptide/NLS show low cytotoxicity similar to 






Figure 4-9  MTT assay for evaluating cytotoxicity of LPD+PA+NLS at different 
liposome concentrations. LipofectamineTM 2000 and LPD without peptide were 
used as a control. The cell viability of samples with LPD with PA and NLS above 
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liposome concentrations 50mM was higher than 60%. LipofectamineTM 2000 had 
obvious toxicity as concentrations over 20 mM. The data points represent the 
mean ±SD of three trials. 
 
4.4 Discussion 
The self-renewing and differentiation ability of stem cells has drawn increasing 
attention of researchers in the field of stem cell therapy and regenerative medicine as 
next-generation therapeutic method. Although embryonic stem cell is one of the best 
types of stem cells for this purpose, the legal and moral controversies have hindered the 
clinical use of embryonic stem cells and thus promoted the discovery and use of adult 
stem cells.  MSCs are adult stem cells that could be isolated from various sources, 
mostly bone marrow. Compared to embryonic stem cells, the advantages of using MSCs 
for cell therapy and regenerative medicine include: (1) they could be isolated from the 
patients themselves to avoid the possible immunological rejections induced by stem cell 
implantation; (2) they tend to differentiate into various types of cells, such as 
osteoblasts, adipocytes, and chondroblasts, which could be used for fabricating 
biomaterials or artificial organs; (3) they are easy to culture and expand in vitro thus 
mass production for clinical uses could be easily reached in very low cost and effort. 
Transplanting MSCs harboring therapeutic gene or drug into the injured area has been a 
promising novel therapeutic method for various traditionally incurable degenerative 
diseases by utilizing the self-renewing ability and multiple differentiating potencies of 
MSCs.  This has become a basic principle of applying MSCs in the field of regenerative 
cell therapy. Moreover, the use of non-viral carrier or nanomaterial to deliver 
therapeutic molecules would circumvent the moral and controversial issues associated 
with viral carriers. However, relatively low delivery efficiency of non-viral carrier for 
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therapeutic substances into MSCs has limited this practical application of MSCs [157]. 
This quests the multifunctional carrier with high affinity to MSCs by conjugating with a 
binding agent of MSCs. Therefore, it is necessary to identify the binding motif with 
high affinity binding to MSCs in order to facilitate the systemic delivery of therapeutic 
substances into MSCs.  
Phage display is the high throughout selection technique applied in this work to 
identify specific rat mesenchymal stem cell binding peptides. Usually, a randomly 
phage-displayed peptide library (up to 109 diversity) is panned against targets for 
several rounds. By washing out non-bound phages and amplifying eluted bound phages 
as a new library for subsequent rounds, peptide sequences with higher binding affinity 
than others can be picked out. In this work, 78 sequences were selected and analyzed 
after 4 rounds of phage selection against rat MSCs by a bioinformatics tool RELIC. It 
resulted in peptide HMGMTK defined as rMSCs-binding peptide, which is further 
confirmed by fluorescent imaging. The peptide HMGMTK showed higher binding 
affinity to MSCs compared to that of scrambled peptide, and phage harboring the same 
sequences could competitively inhibit this favorable binding. These results suggested 
that HMGMTK is a MSC binding motif with higher affinity, by which we may be able 
to increase the non-viral gene delivery efficiency to MSCs.  
In order to prove our hypothesis, we integrate MSC-binding peptide HMGMTK 
into a non-viral gene vector, LPD system, to deliver a model EGFP gene and then 
evaluated the transfection efficiency as well as the cytotoxicity. The percentage of cells 
that express GFP genes obtained from FACS technique is our criteria for evaluating the 
gene transfection efficiency of vectors. The results proved that peptide HMGMTK 
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could enhance the liposome-mediated gene delivery to rMSCs. Transfection efficiency 
of LPD+PA complex to rat mesenchymal stem cells was ~13%, a more than doubling 
that of LPD particles only without any peptides (~4%), and widely used commercial 
liposome vector LipofectamineTM (~6%). (Figure 4-8A) LPD+PA complex has even 
twice transfection level comparing to LPD+control peptide complex that does not 
recognize rMSCs. These above suggested that peptide HMGMTK could benefit 
liposome-mediated gene delivery into rMSCs, specifically. This is consistent to our 
expectation, as the rMSCs-recognizing property of peptide HMGMTK would make 
gene vector bearing them bind to rMSCs more favorably and thus increase gene 
transfection level.  
For doubling the enhancement of gene transfer efficiency, we involved the 
nuclear localizing signal (NLS) motif into the liposome complex. Nuclear localization 
signal is the peptide DPKKKRKV derived from the simian virus 40 large tumor antigen, 
a binding mediator of the karyophilic protein and importin α[181]. The NLS peptide 
was found to play a vital role in achieving the high levels of gene expression and is 
sufficient to carry exogenous DNA through the nuclear membrane to the cell nucleus 
which is a major concern of gene delivery technologies[182]. Recent gene therapy 
research showed that three-fold reiterated NLS peptide (sequence 
DPKKKRKVDPKKKRKVDPKKKRKV) has the capability of enhancing non-viral 
gene delivery to MSCs[170]. Thus, we expect that involving this sequence into the 
system could further increase the transfection efficiency of LPD+PA vector. Our result 
confirmed this expectation. Integrating NLS motif into liposome complex together with 
rMSCs-binding peptide has highest transfection efficiency among all the liposome-
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based vectors that we have tested. The optimum mass ratio of plasmid to peptide in 
LPD+PA+NLS is 1:6 at which the maximum transgenic level 19.43% was obtained. Its 
capability of enhancing gene delivery is also comparable to other common non-viral 
gene vectors such as polymer[183-186], inorganic nanoparticles[187, 188]. 
The cytotoxicity of targeting peptide-combined LPD complex remains low 
compared to LipofectamineTM (Figure 4-9) and other common non-viral carriers[183, 
184, 187]. The result proved that identified MSC-binding peptide HMGMTK is able to 
serve as a high-affinity binding motif of MSCs to improve the efficiency of systemic 
delivery of therapeutic gene or drug to MSCs. This finding pointed out that improving 
delivery efficiency of stem cell based systemic therapy could be one of the possible 
applications of rMSC binding peptide and also advanced the research of non-viral gene 
delivery to rMSCs.  
Moreover, deeper research found the selected peptides showed higher similarity 
to the known ligands whose receptors are present on the rMSC surface than those absent 
ones, while peptide HMGMTK showed significantly high similarity to the N-terminal 
signaling region of CX3CL1, the ligand of CX3CR1 receptor present on rMSC. We 
believe that in addition to the higher binding affinity of the peptide HMGMTK, this 
peptide can benefit the systemic gene or drug delivery by acting as an agonist of 
CX3CR1 and activating the receptor mediated endocytosis. It has been believed that, in 
the normal physiological condition, a G-protein coupled receptor (GPCR) which 
normally has 7-transmembrane domains typically undergoes endocytosis after being 
activated by an agonist or ligand and initiating a signaling cascade[189]. This receptor-
mediated endocytosis is responsible for regulating the density of a cell surface receptor 
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staying within a proper range. Two cell uptake pathways are involved in this ligand-
induced receptor internalization: clathrin-mediated endocytosis[189] and cavelae-
mediated endocytosis[190]. The cell uptake of various particles could be also mediated 
by this mechanism, such as virus, toxins, drugs, etc. A variety of nanoparticles and 
nanovehicles were reported to be uptaken by cells via receptor-mediated endocytosis 
[191-194].  
 
4.4.1 Peptide HMGMTK may serve as CX3CL1-like ligand and bind to 
CX3CR1 which may narrow the putative binding site region of CX3CL1  
CX3CR1 is one of the GPCRs. The protein structure of chemokine domain of 
CX3CL1 has been solved by NMR and X-ray crystallography (Figure 4-10) [195, 196]. 
Further investigations have also been conducted to explore the detailed mechanism of 
binding interaction [195, 197-199], yet it is still not fully understood to date. The 
protein structure is different from common chemokines. It consists of a N-terminal 
chemokine domain whose structure is similar to common chemokine structure, a mucin-
like stalk, a hydrophobic transmembrane domain and a cytoplasmic tail. It is well 
believed that the N-terminal region of chemokine is crucial for ligand-receptor binding 
by acting as a key signaling domain. Deletion and mutation in this region has been 
proved to result in interfering the signaling induction and sometimes the affinity 
interactions with their receptors [169, 200].  
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Figure 4-10   The tertiary structure of chemokine domain of CX3CL1. It consists 
of a flexible N-terminal region three beta strands (in yellow), and a C-terminal 
helix (in red). The six amino acids showing highest similarity to peptide 
HMGMTK are marked in magenta.  
 
Although the distinctive mechanism of agonist-induced endocytosis for 
CX3CR1 is still unknown, unlike that for CCR5 and CXCR4[202], the fact that 
CX3CR1 may also mediate endocytosis is acceptable. Therefore, considering the 
analysis that the HMGMTK peptide showed the greatest similarity to the chemokine 
domain of CX3CL1, the unique ligand of CX3CR1, peptide HMGMTK may also be 
able to serve as an agonist of CX3CR1 to activate the receptor-mediated endocytosis. 
Therefore, we proposed that the higher affinity of identified peptide HMGMTK may be 
achieved via CX3CL1-CX3CR1 axis. Further experiments are undergoing to prove this 
hypothesis. On the other hand, this identification and matching result may also define 
the exact binding site of CX3CL1. It is possible that HLGMTK motif in the N-terminus 
contribute most to the binding affinity of CX3CL1, similar to RFFRESH motif in 
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CXCL12 [203]. This 6 amino acid sequence may be also responsible for the chemokine 
functions, such as cell migration and adhesion.  H(L/M)GMTK may be another global 
cell adhesion motif next to RGD motif found in fibronectin [204]. It may be the key 
region for the potential functions of CX3CL1 including cell proliferation, differentiation 
and bone formation of MSCs.  
 
4.4.2 MSC binding peptide HMGMTK may serve as a binding motif and 
agonist of CX3CR1 for facilitating the systemic delivery of gene or drug to 
MSCs via receptor mediated endocytosis and improving the use of MSCs in the 
field of cell therapy and regenerative medicine 
Besides the potential contribution to proteomics and cell studies, peptide 
HMGMTK may be able to serve as a high-affinity binding motif of MSCs to improve 
the efficiency of systemic delivery of therapeutic gene or drug to MSCs. Transplanting 
MSCs harboring therapeutic gene or drug into the injured area has been a promising 
novel therapeutic method for various traditionally incurable degenerative diseases by 
utilizing the self-renewing ability and multiple differentiating potency of MSCs.  This 
has become a basic principle of using MSCs in the field of regenerative cell therapy. 
Moreover, the use of non-viral carrier or nanomaterial to deliver therapeutic molecules 
would circumvent the moral and controversial issues associated with viral carriers. 
However, relatively low delivery efficiency of non-viral carrier for therapeutic 
substances into MSCs has limited this practical application of MSCs [157]. This quests 
the multifunctional carrier with high affinity to MSCs by conjugating with a binding 
agent of MSCs. Therefore, it is necessary to identify the binding motif with high affinity 
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binding to MSCs in order to facilitate the systemic delivery of therapeutic substances 
into MSCs. The peptide HMGMTK identified in this work showed higher binding 
affinity to MSCs than that of scrambled peptide, and phage harboring the same 
sequences could competitively inhibit this favorable binding. These results suggested 
that HMGMTK is one of the MSC binding motifs, which could increase the delivery 
efficiency contributed by higher binding affinity. 
However, there is another scenario besides higher binding affinity that may 
benefit the systemic gene or drug delivery: peptide HMGMTK may act as an agonist of 
CX3CR1 and activate the receptor mediated endocytosis. It has been believed that, in 
the normal physiological condition a G-protein coupled receptor (GPCR) which 
normally has 7-transmembrane domains typically undergoes endocytosis after being 
activated by an agonist or ligand and initiatings a signaling cascade[189]. This receptor 
endocytosis is responsible for regulating the density of a cell surface receptor staying 
within a proper range. Two cell uptake pathways are involved in this ligand-induced 
receptor internalization: clathrin-mediated endocytosis[189] and cavelae-mediated 
endocytosis[190]. The cell uptake of various particles could be also mediated by this 
mechanism, such as virus, toxins, drugs, etc. A variety of nanoparticles and 
nanovehicles were reported to be uptake by cells via receptor mediated endocytosis 
[191-194]. CX3CR1 is one of the GPCRs. Although the distinctive mechanism of 
agonist-induced endocytosis for CX3CR1 is still unknown, unlike that for CCR5 and 
CXCR4[202], the fact that CX3CR1 may also mediate endocytosis is acceptable. 
Therefore, considering the analysis result that the HMGMTK peptide showed the 
greatest similarity to the chemokine domain of CX3CL1, the unique ligand of CX3CR1, 
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and thus may possibly associate with CX3CR1, peptide HMGMTK may also be able to 
serve as an agonist of CX3CR1 to activate the receptor-mediated endocytosis. This 
potential property of peptide HMGMTK may facilitate the cell entry of a particle 
having this peptide to deliver the therapeutic gene or drug. 
 
4.5 Conclusion 
Peptide HMGMTK was identified as MSC binding peptide through phage 
display-based affinity selection. A LPD complex was constructed with this peptide and 
NLS peptide as an effective MSC gene delivery vector. Fluorescence imaging results 
proved the MSC targeting property of selected peptide. High similarity between peptide 
HMGMTK and signaling region of CX3CL1 was found by bioinformatics analysis. 
CX3CL1 is one of a chemokine whose receptor CX3CR1 existed on MSC surface. This 
may suggest a possible mechanism that could explain the MSC homing effect of the 
selected peptide. Later on, we built up a multifunctional complex as an effective MSC 
gene delivery vector by combining LPD, selected MSC peptide and NLS peptide. The 
transfection mediated by the resultant complex LPD+PA+NLS showed higher 
efficiency and specificity compared to those achieved by LPD only, LPD with control 
peptide, or LPD with PA only. Meanwhile, MTT results supported the low cytotoxicity 
of LPD+PA+NLS complex. All together, a conclusion could be draw that a novel rMSC 
binding peptide with sequence HMGTMK was identified and could be used to build up 
a promising gene carrier for facilitating liposome-mediated MSC gene delivery as 
shown in Figure 4-1.   
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Chapter 5: Summary of Results and Future Directions 
5.1 Summary of results 
The filamentous shape of bacteriophages in nanorange and its programmable 
surface chemistry make it a great template for phage-based material synthesis and 
assembly. These phage-based materials have many applications including tissue 
engineering, drug and/or gene delivery, cancer treatment, bioimaging, etc. In previous 
chapters, the use of bacteriophage as template for nanosynthesis and the applications of 
tissue engineering and drug/gene delivery are discussed.  
Chapter 2 demonstrates the hydroxyapatite crystals can be nucleated on self-
assembled bacteriophages in a preferred c-axis orientation. The resultant bacteriophage 
may serve as the building block to substitute collagen and form bone implant. It has a 
great potential in the field of tissue engineering. This work also proved that the driving 
force of phage self-assembly is beta sheet secondary structure and beta sheet between 
phage bundles can induce the orientated nucleation of hydroxyapatite crystals.  The beta 
sheet formation can be used as a general method to precisely control assemblies 
between engineerable biomaterials. In natural bone, HAP crystals are nucleated and 
grown with their c-axis preferentially parallel to collagen fibrils. In the work of Chapter 
2, we also found that HAP crystals were also nucleated on EQ bundles with their c-axis 
preferentially parallel to phage bundles, which greatly mimicked the base level of 
hierarchical structure of natural bone. We further found that calcium ions were attracted 
to the glutamic acids and aspartic acids of peptide E and Q with a pattern matching with 
calcium ions on the (001) plane of HAP crystals. This specific matching then induced 
the HAP nucleation on the beta sheet and the growth along the c-axis. This work 
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provided the proof for a new way of fabricating bone biomaterials by biomimicking and 
bioinspiration. 
Bacteriophage-gold nanocomposite was constructed in the work of Chapter 3 to 
use as a model to study the optimum condition for best TEM imaging of bioinorganic 
nanohybrids. In this work, wild type M13 phage was combined with gold nanoparticles 
to form phage-gold nanocomposite. Most Au-NPs were aligned into large belts, forming 
a net-like structure. TEM imaging of negatively stained bioinorganic nanohybrids is a 
simple way to characterize these nanostructures that may have biomedical functions. By 
studying the effects of different factors on the negative staining of phage-gold 
nanocomposites, we found that the optimum staining conditions for these bioinorganic 
nanohybrids are using 0.5% UA solution with pH 4.5, staining for 10 seconds, and 
rapidly drying the stains. This work demonstrates that each staining factor has an 
influence to the final appearance of stained specimens and optimum staining condition 
needs to be customized to the individual type of bioinorganic nanohybrids. The effects 
of each staining factor and a general guideline for selecting staining condition were 
provided in this work. Therefore, this research provides useful information for the 
characterization of bioinorganic nanomaterials by TEM imaging. It will help the 
research in the field of nanomaterials and bionanotechnology. 
Different from Chapter 2 and Chapter 3, Chapter 4 is about identifying target-
specific motif by affinity selection based on phage display technique to improve 
transfection efficiency and specificity of gene or drug delivery. In this work, we did cell 
panning on primary mesenchymal stem cells and identified peptide HMGMTK as MSC 
binding peptide. Further bioinformatics analysis suggests that peptide HMGMTK has 
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high similarity to the signaling regions of chemokine CX3CL1. This may suggest a 
possible mechanism that could explain the MSC homing effect of the selected peptide. 
We then constructed a novel and effective mesenchymal stem cell gene delivery vector 
by liposome/protamine/DNA complex incorporating with identified MSC-targeting 
motif and Nuclear localized signal (NLS) motif. Through several evaluations, we 
proved that this resultant complex is multifunctional, effective, but low-cytotoxic MSC 
gene delivery vector. The transfection mediated by the resultant complex 
LPD+PA+NLS showed higher efficiency and specificity compared to those achieved by 
LPD only, LPD with control peptide, or LPD with PA only. Meanwhile, MTT results 
supported the low cytotoxicity of LPD+PA+NLS complex. Based on all the results, we 
can conclude that a novel rMSC binding peptide HMGMTK was identified and could 
be used to build up a promising gene carrier for facilitating liposome-mediated MSC 
gene delivery. 
 
5.2 Outlook and future directions 
5.2.1 Tissue engineering for bone regeneration 
An ideal bone material should have osteoconductivity, osteogenity, and 
osteoinductivity. It should have great mechanical properties to serve as a scaffold of 
resultant bone material. It should have appropriate surface to promote cell attachment, 
differentiation, and proliferation. It should also be able to stimulate HAP nucleation and 
oriented growht. Hydroxyapaptite by itself is a great bioceramic for fabricating bone 
materials due to its excellent biocompartibility and the ability to enhance cell adhesion 
and proliferation. However, it lacks osteoinductivity to initiate crystal nucleation. 
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Introducing HAP nucleating peptides by phage display is the key I used in the work of 
Chapter 2 to fix this problem. Chapter 2 describe genetically engineered phages with 
HAP nucleating peptides displayed on the surface can form bundles as a bone scaffold 
and nucleate hydroxyapatite to form bioactive composite materials for cell adhesion and 
proliferation. The following work can be done to further dig the findings: (1) Cell 
culture test and characterization to examine the ability of the genetically engineered 
phage scaffold to enhance cell adhesion and proliferation. I may coat a film of 
genetically engineered phage scaffold onto the cell culture plate and culture 
mesenchymal stem cell to see how the cells response to the phage scaffolds. In vivo 
animal test can be expected if ex vivo cell culture test is successful. (2) One of the 
advantages of phage as bone scaffold is their tunable surface chemistry by genetic 
modifications. This may offer more promising directions of using phages in the study of 
tissue engineering.  
 
5.2.2 Proteomic analysis (Ligand-receptor/Antibody-antigen interaction) 
Chapter 4 describes how to take advantage of phage display technique to 
identify a targeting motif that can specifically bind to live cells and give a promising 
method for proteomic studies on cells. Phage display has many advantages for studying 
proteomics: (1) no pre-knowledge of the target is needed to study the binding proteins 
to the target. This is a great way to predict new interacting proteins since other common 
methods can only confirm the proposed interaction. (2) The identified binding peptides 
can provide insight of the precise binding site to the targets due to the much smaller size 
of identified peptides selected by phage display than other traditional affinity selection 
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methods. (3) Phage display biopanning is time and cost-effective. The experimental 
procedure of affinity selection by phage display just needs several weeks to finish and 
the results can be analyzed by bioinformatics software such as RELIC.  
In the work stated in Chapter 4, the identified MSC-binding motif HMGMTK 
was found to have great similarity to the chemokine domain of CX3CL1, the unique 
binding ligand of CX3CR1. This matching result may define the exact binding site of 
CX3CL1. It is possible that HLGMTK motif in the N-terminus contribute most to the 
binding affinity of CX3CL1, similar to RFFRESH motif in CXCL12 [203]. Therefore, 
we proposed that the higher affinity of identified peptide HMGMTK may be achieved 
via CX3CL1-CX3CR1 axis. Further experiments need to do to prove this hypothesis. 
The work in Chapter 4 describes a reasonable way for studying protein-protein 
interactions is to use the potential binding sites identified from biopanning process to 
narrow the target binding domains and direct practical experiments.  
 
5.2.3 Customized diagnosis and targeted therapy 
Biomedical researchers are continuously pursuing a more efficient and reliable 
therapeutic delivery. An ideal carrier (1) should be able to efficiently deliver the 
therapeutic materials (genes or drugs) into the target cell, (2) should be protective to the 
gene inside and biocompatible so that it will not cause cytotoxicity, or most importantly, 
(3) should be target-specific like a “magic bullet” that will only transfect into specific 
target cells without harming neighbouring healthy areas. It is noteworthy that the 
targeting ability is a requirement for these applications since human disease is often 
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associated with protein expression profile abnormalities. Currently, it has been 
commonly accepted that the efficiency and specificity of delivery vehicles can be 
increased by coupling specific targeting ligands with them. Therefore, as an efficient 
target-binder identification system, phage display can facilitate the systematic delivery 
by identifying novel targeting motifs which can incorporate into the delivery vehicles.  
Chapter 4 shows an example of incorporating a novel targeting motif into 
delivery vectors to improve gene delivery efficiency and specificity. The 
multifunctional gene vector built in this work has been proved to have higher efficiency 
and specificity than regular vectors such as commercially available lipofectomine. This 
provides a promising vector for customized therapy by mesenchymal stem cell. Future 
works that can be done to prove it include: (1) In vivo animal test can be expected to 
check the transfection efficiency of the vector to the target organ or tissue. (2) I will 
then obtain human mesenchymal stem cells and use the method in the work of Chapter 
4 to identify a targeting motif to human mesenchymal stem cells which can be 
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